Abst,Sent,Source,Output,Simp. sent,Simp. term,Simp. term acc.,Simp. fluency
Q1_A4,1,Purpose: To determine predictors of best-corrected postoperative visual acuity (VA) in patients who underwent surgical intervention for macula-off rhegmatogenous retinal detachment.,"This study determined predictors of best-corrected visual acuity (VA; vison sharpness) in patients who had surgery for macula-off rhegmatogenous retinal detachment. Rhegmatogenous retinal detachments are breaks of the retina that result in light flashes or ""dark curtains"" in vision.",1,1,1,1
Q1_A4,2,Materials and methods: Primary macula-off retinal detachments from the University of Colorado Primary Rhegmatogenous Retinal Detachment Database (2012-2017) were reviewed.,Case studies from an online database from 2012 to 2017 were reviewed.,1,1,1,1
Q1_A4,3,The primary outcome measure was a postoperative VA of 20/40 or better at least 6 months after surgery.,VA of 20/40 or better at least 6 months after surgery was measured.,1,0,0,1
Q1_A4,4,"Patient demographics, medical history, duration of central vision loss before surgery, examination findings, operative technique, and postoperative findings were analyzed as possible predictors of postoperative visual recovery to 20/40 or better.","Patient demographics, medical history, time without central vision before surgery, exam findings, surgery technique, and post-surgery findings were reviewed as possible predictors of post-surgery visual recovery to 20/40 or better.",0,0,0,0
Q1_A4,5,"Chi-square or Fisher's exact test was used to compare categorical variables, and Wilcoxon rank sum test was used for continuous variables.",Analytical tests were used to compare variables.,1,0,0,1
Q1_A4,6,A multivariable logistic regression analysis was used to determine the adjusted odds ratios and 95% confidence intervals for variables that were significant in the univariable analyses.,Analysis was done on variables deemed significant.,1,0,0,1
Q1_A4,7,Statistical significance was set at p < 0.05.,Statistical significance was given a numerical value.,0,0,0,1
Q1_A4,8,Results: One hundred thirty-one patients met inclusion criteria.,The study included 131 patients.,1,1,1,1
Q1_A4,9,Eighty-one (61.8%) patients achieved a postoperative VA of 20/40 or better 6 or more months after surgery.,Eighty-one patients achieved a VA of 20/40 or better 6 or more months after surgery.,1,0,0,1
Q1_A4,10,"Patients with a single retinal break were more likely than patients with more than one break to reach a postoperative VA of 20/40 or better (76.9% vs. 55.4%, p = 0.021).",Patients with a single retinal break were more likely than those with more breaks to reach a VA of 20/40 or better after surgery.,1,0,0,1
Q1_A4,11,Patients with a better preoperative logMAR VA had better postoperative VA (p = 0.021).,Patients with a better VA before surgery had better VA after surgery.,1,1,1,1
Q1_A4,12,Duration of central vision loss prior to surgical repair was not related to final postoperative VA in this particular study.,Time with central vision loss prior to surgery was not related to final VA after surgery.,0,0,0,1
Q1_A4,13,Conclusion: Postoperative recovery of visual acuity to 20/40 or better was significantly more common in patients with a single retinal break as well as in patients with better preoperative visual acuity.,Recovery after surgery of visual acuity to 20/40 or better was much more common in patients with a single retinal break and in those with better visual acuity before surgery.,1,1,1,1
Q1_A4,14,Duration of central vision loss prior to surgical repair was not significantly associated with postoperative VA.,Time with central vision loss before surgery was not highly linked with VA after surgery,0,0,0,1
Q2_A6,1,Background: Our primary objective was to determine the rate of persistent Trichomonas infection among pregnant women posttreatment.,We mainly aimed to find the rate of pregnant women who had long-lasting Trichomonas infection.,1,1,1,1
Q2_A6,2,The secondary objective was to determine if oral multidose metronidazole was associated with fewer cases of persistent Trichomonas compared with single-dose treatment.,"We also wanted to find out if long-lasting Trichomonas infection cases were fewer with multiple doses of metronidazole, an antibiotic, versus one dose taken by mouth.",0,1,1,1
Q2_A6,3,Methods: This is a retrospective cohort study of women diagnosed with genital Trichomonas vaginalis from 2008 to 2017.,Our study included women with Trichomonas vaginalis (a parasite) from 2008 to 2017.,1,1,1,1
Q2_A6,4,We calculated the rate of persistent Trichomonas by dividing the number of positive Trichomonas tests collected 21 days or longer posttreatment by the total number of women treated and retested.,We calculated the rate of long-lasting Trichomonas by dividing the number of women who tested positive for Trichomonas 21 days or longer after treatment by the total number of women treated and retested.,-1,-1,0,1
Q2_A6,5,Bivariate analysis was performed to compare the rates of positive tests after single and multidose metronidazole.,We did a statistical test to compare the rates of positive tests after one and multiple doses of metronidazole.,1,1,1,1
Q2_A6,6,Multivariate logistic regression was used to evaluate factors associated with persistent infection.,We did another statistical test to rate things related to long-lasting infection.,1,1,1,1
Q2_A6,7,Results: Five hundred forty-two women with 565 pregnancies were diagnosed with Trichomonas infection.,We found that 542 women with 565 pregnancies had Trichomonas infection.,1,1,1,1
Q2_A6,8,The majority of subjects were prescribed either single-dose (n = 352) or multidose metronidazole (n = 74).,Most of the women took either one dose (n = 352) or multiple doses (n = 74) of metronidazole.,1,0,1,1
Q2_A6,9,Posttreatment Trichomonas tests were collected 21 days or longer in 326 subjects and 44% (143) were positive.,Three hundred and twenty-six women were tested for Trichomonas 21 days or longer after treatment and 44% had Trichomonas infection.,0,1,1,1
Q2_A6,10,"Rates of positive Trichomonas tests among women receiving single-dose and multidose regimens were similar (45% vs. 40%, P = 0.50).",Women who took one dose and multiple doses of metronidazole had similar rates of positive Trichomonas tests.,1,1,1,1
Q2_A6,11,"Women who had ≥1 pregnancy affected by Trichomonas infection were more likely to have a positive test posttreatment (adjusted odds ratio, 20.1; 95% confidence interval, 1.9-215.3).",Women who had one or more pregnancy affected by Trichomonas infection were more likely to have Trichomonas infection when tested after treatment.,1,1,1,1
Q2_A6,12,"Obese women were less likely to have a positive test posttreatment (adjusted odds ratio, 0.3; 95% confidence interval, 0.1-0.9).",Obese women were less likely to have Trichomonas infection when tested after treatment.,1,1,1,1
Q2_A6,13,"Conclusions: Given high rates of positive Trichomonas tests and increased detection with nucleic acid amplification tests (NAATs), all pregnant women should be retested with NAATs approximately 3 weeks posttreatment.","We conclude that due to high rates of people testing positive for Trichomonas infection and better detection with lab tests that use a patient sample, all pregnant women should be retested will lab testing about 3 weeks after treatment.",-1,1,1,0
Q2_A6,14,Further studies are needed to determine the most effective treatment of Trichomonas infection in pregnant women.,More studies are needed to figure out the best treatment of Trichomonas infection in pregnant women.,1,1,1,1
Q3_A10,1,Objective: To assess the effect on hemostasis parameters of a new combined oral contraceptive (COC).,The goal of this study was to assess the effect on hemostasis (body regulation) parameters of a new combined oral contraceptive (COC). Contraceptives are medications to prevent pregnancy.,1,0,-1,1
Q3_A10,2,"Study design: In this randomized, single centre, open-label, exploratory study, healthy women received either 15 mg estetrol/3 mg drospirenone (E4/DRSP) (n = 39), 30 mcg ethinylestradiol/150 mcg levonorgestrel (EE/LNG) (n = 30), or 20 mcg ethinylestradiol/3 mg drospirenone (EE/DRSP) (n = 32) for six 28-day cycles.","In this study, healthy women were allocated to one of three groups for six 28-day menstrual cycles. These groups were: 15 mg estetrol/3 mg drospirenone (E4/DRSP), 30 mcg ethinylestradiol/150 mcg levonorgestrel (EE/LNG), or 20 mcg ethinylestradiol/3 mg drospirenone (EE/DRSP).",1,1,1,1
Q3_A10,3,"Blood was collected at baseline, cycle 3, and cycle 6.","Blood was collected before the study began (baseline), cycle 3, and cycle 6.",1,1,1,1
Q3_A10,4,"Median change from baseline was evaluated for procoagulant, anticoagulant, and fibrinolytic parameters, and for sex hormone-binding globulin (SHBG).","Change from baseline was evaluated for procoagulant (pre-clotting factors), anticoagulant (anti-clotting factors), and fibrinolytic parameters (dissolve blood clots), and for sex hormone-binding globulin (SHBG).",0,1,1,1
Q3_A10,5,"Results: Median change of endogenous thrombin potential (ETP) based activated protein C sensitivity resistance (APCr) at cycle 6 was +30% for E4/DRSP, +165% for EE/LNG (p-value <0.05 vs E4/DRSP), and +219% for EE/DRSP (p-value <0.05 vs E4/DRSP).",Change of internal thrombin potential (ETP) based activated protein C sensitivity resistance (APCr) at cycle 6 was increased for all groups.  APCr is an increased tendency of the blood to clot.,-1,-1,0,1
Q3_A10,6,"Changes to prothrombin fragment 1 + 2 and SHBG for E4/DRSP, EE/LNG, and EE/DRSP were +23%, +71%, and +64% (p-value <0.05 vs E4/DRSP); and +55%, +74% and +251% (p-value <0.05 vs E4/DRSP), respectively.",Changes to prothrombin fragment 1 + 2 and SHBG increased for all groups. High prothrombin fragment 1 + 2 indicates a patient is more likely to have a clogged blood vessel.,0,0,0,1
Q3_A10,7,"At cycle 6, changes to other hemostasis parameters for E4/DRSP were similar or smaller than for EE/LNG or EE/DRSP.","At cycle 6, changes to group E4/DRSP were similar or smaller than groups EE/LNG or EE/DRSP.",0,0,0,1
Q3_A10,8,"Conclusions: In this study, changes in hemostasis parameters after treatment with 6 cycles of E4/DRSP were smaller or similar to those observed for EE/LNG.",This study showed changes in hemostasis parameters after treatment with 6 cycles of E4/DRSP were smaller or similar to those observed for EE/LNG.,0,0,0,1
Q3_A10,9,"Similar, but more pronounced changes were also observed versus EE/DRSP, which supports the hypothesis that the effect of COCs on hemostasis parameters is mainly mediated by the estrogenic component.","Similar, but more pronounced changes were also observed versus EE/DRSP. This data supports the theory that the effect of COCs on hemostasis parameters is altered by female hormones.",0,0,0,1
Q3_A10,10,Further studies are needed to provide more insight into the venous thromboembolic risk of E4/DRSP.,More research is needed to explain how E4/DRSP was more likely to suffer blood clots in the veins.,1,1,1,1
Q3_A10,11,Implications statement: This study reports that the effects on hemostasis parameters of a COC containing 15 mg E4/3 mg DRSP are less or similar to those for EE/LNG or EE/DRSP.,This study reports that the effects on hemostasis parameters of a COC containing 15 mg E4/3 mg DRSP are less or similar to those for EE/LNG or EE/DRSP.,0,0,0,1
Q3_A10,12,It also demonstrates that the choice of estrogen modulates the effects of COCs on hemostasis parameters.,This study also shows that the choice of estrogen controls the effects of COCs on hemostasis parameters.,1,0,0,1
Q4_A4,1,"Purpose: This study investigated the prevalence, location, and severity of neck and shoulder pain (NSP), its disturbance of quality of life (QOL), and the factors related to NSP in Japanese postpartum women.","This study investigated the frequency, location, and severity of neck and shoulder pain (NSP), how NSP effects quality of life (QOL), and the factors related to NSP in Japanese postpartum (following childbirth) women.",-1,1,1,1
Q4_A4,2,Materials and methods: The study involved 308 postpartum women who had a medical examination one month after delivery.,The study involved 308 postpartum women who had a medical examination one month after delivery.,1,0,1,1
Q4_A4,3,The questionnaire consisted of the background and details of NSP.,The questionnaire asked about the patients' backgrounds and details of NSP.,1,1,1,1
Q4_A4,4,"Mood states were evaluated using the Profile of Mood States-Brief (POMS-B), Japanese Version.",The patients' moods was were evaluated.,1,1,1,1
Q4_A4,5,"Results: The prevalence of NSP was 73.1%, one-fourth of which occurred after birth.","NSP occurred in most women, with one-fourth happening after birth.",1,1,1,1
Q4_A4,6,The most common area was the superior part of the trapezium muscles.,"The most common area NSP occurred was within the upper back, upper shoulders, and neck.",1,1,1,1
Q4_A4,7,"Prevalence was associated with past history of premenstrual syndrome (PMS), anemia during pregnancy, time per breastfeeding, and the mean POMS-B Fatigue score.","NSP frequency was linked with past history of premenstrual syndrome (PMS), lack of healthy red blood cells during pregnancy, time per breastfeeding, and mood test scores.",0,1,1,1
Q4_A4,8,"Total breastfeeding time a day, the mean POMS-B score for Fatigue, Confusion, Anger-Hostility, and Depression were significantly higher for ""worse"" after birth than those for ""no-change/relief"".","Total breastfeeding time a day along with the mood test scores for Fatigue, Confusion, Anger-Hostility, and Depression were higher in women with ""worse"" NSP after birth than those with ""no-change/relief"".",-1,0,1,1
Q4_A4,9,The disturbance of daily life due to NSP in postpartum women with past history of PMS and Hiesho were significant higher than that for women without those.,The disturbance of daily life due to NSP in postpartum women with past history of PMS and Hiesho (cold hands and feet) were significant higher than that for women without those.,0,0,1,1
Q4_A4,10,Conclusions: The prevalence of NSP in postpartum women was very high.,The frequency of NSP in postpartum women was very high.,1,0,1,1
Q4_A4,11,"The factors which affect NSP were the mental states, breastfeeding, past history of PMS, and anemia during pregnancy.","NSP is affected by mental states, breastfeeding, past history of PMS, and lack of healthy red blood cells during pregnancy.",1,1,1,1
Q5_A4,1,"Importance: There is considerable public and scientific debate as to whether screen use helps or hinders early child development, particularly the development of language skills.","There is a large debate as to whether screen use helps or hurts early child development, particularly the development of language skills.",1,1,1,1
Q5_A4,2,"Objective: To examine via meta-analyses the associations between quantity (duration of screen time and background television), quality (educational programming and co-viewing), and onset of screen use and children's language skills.","This study analyzed the links between quantity (duration of screen time and background television), quality (educational programming and co-viewing), and onset of screen use and children's language skills.",0,0,0,1
Q5_A4,3,"Data sources: Searches were conducted in MEDLINE, Embase, and PsycINFO in March 2019.",Online databases were search for scientific evidence in March 2019.,1,1,1,0
Q5_A4,4,The search strategy included a publication date limit from 1960 through March 2019.,Only publications from 1960 through March 2019 were included.,1,1,1,1
Q5_A4,5,Study selection: Inclusion criteria were a measure of screen use; a measure of language skills; and statistical data that could be transformed into an effect size.,Inclusion criteria were a measure of screen use; a measure of language skills; and statistical data that could be transformed into an effect size.,0,0,0,1
Q5_A4,6,Exclusion criteria were qualitative studies; child age older than 12 years; and language assessment preverbal.,Exclusion criteria were qualitative studies; children older than 12 years; and language assessment before the development of speech (i.e. infants).,0,1,1,1
Q5_A4,7,"Data extraction and synthesis: The following variables were extracted: effect size, child age and sex, screen measure type, study publication year, and study design.","The following variables were extracted: effect size, child age and sex, screen measure type, study publication year, and study design.",0,0,0,1
Q5_A4,8,All studies were independently coded by 2 coders and conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.,All studies were independently reviewed according to preexisting review guidelines.,0,0,0,1
Q5_A4,9,"Main outcomes and measures: Based on a priori study criteria, quantity of screen use included duration of screen time and background television, quality of screen use included co-viewing and exposure to educational programs, and onset of screen use was defined as the age children first began viewing screens.",Quantity of screen use included duration of screen time and background television. Quality of screen use included co-viewing and exposure to educational programs. Onset of screen use was defined as the age children first began viewing screens.,1,1,1,1
Q5_A4,10,The child language outcome included assessments of receptive and/or expressive language.,The child language outcome included assessments of receptive (understanding) and/or expressive (use of words) language.,1,1,1,1
Q5_A4,11,Results: Participants totaled 18 905 from 42 studies included.,"Participants totaled 18,905 from 42 studies included.",1,1,1,1
Q5_A4,12,Effect sizes were measured as correlations (r).,Effect sizes were measured as correlations (r).,0,0,0,1
Q5_A4,13,"Greater quantity of screen use (hours per use) was associated with lower language skills (screen time [n = 38; r = -0.14; 95% CI, -0.18 to -0.10]; background television [n = 5; r = -0.19; 95% CI, -0.33 to -0.05]), while better-quality screen use (educational programs [n = 13; r = 0.13; 95% CI, 0.02-0.24]; co-viewing [n = 12; r = 0.16; 95% CI, 0.07-.24]) were associated with stronger child language skills.",Greater quantity of screen use (hours per use) was associated with lower language skills. Better-quality screen use were associated with stronger child language skills.,1,1,1,0
Q5_A4,14,"Later age at screen use onset was also associated with stronger child language skills [n = 4; r = 0.17; 95% CI, 0.07-0.27].",Later age at screen use onset was also associated with stronger child language skills.,0,0,0,1
Q5_A4,15,"Conclusions and relevance: The findings of this meta-analysis support pediatric recommendations to limit children's duration of screen exposure, to select high-quality programming, and to co-view when possible.","These findings support pediatric recommendations to limit children's duration of screen exposure, to select high-quality programming (educational shows), and to co-view when possible.",1,1,1,1
Q6_A4,1,Animal-assisted intervention is gaining attention as a stress reduction modality.,Animal-assisted intervention is becoming more popular as a way to reduce stress.,1.0,1.0,1.0,1.0
Q6_A4,2,"Quantitative data demonstrate its effectiveness, as a recent study published in AJHPM supported that a Veterans Affairs (VA) hospital facility dog paired with a palliative care psychologist had a measurable impact on salivary cortisol levels and heart rate in hospitalized veterans.",Measurable data show animals-assisted intervention works. A recent study showed that a hospital dog combined with a psychologist who helps to ease suffering in patients with serious illness changed cortisol (stress chemical) levels in saliva and heart rates in veterans in the hospital.,1.0,1.0,1.0,1.0
Q6_A4,3,There remains an important role for qualitative insights.,Non-numerical information is also important.,1.0,1.0,1.0,1.0
Q6_A4,4,"The Denver VA palliative care team learned a range of lessons from the sudden loss of their facility dog, many of which relate directly to palliative care.","The sudden death of a hospital dog taught a team of healthcare workers that work to ease suffering in people with serious illness many things, especially related to easing suffering in people with serious illness.",0.0,1.0,1.0,1.0
Q6_A4,5,"The importance of communication, adjusting to changing teams, and the need for consultation and support based in shared goals and values all became evident in the course of the facility dog's illness.","While the dog was sick, the healthcare team learned about the importance of communication, adjusting to changing teams, and the need for discussion and support based in shared goals and values.",0.0,1.0,1.0,1.0
Q6_A4,6,"After her death, lessons shifted to grief and loss and how providers, patients, and a community care for each other.","After the dog died, the healthcare team learned about grief and loss and how healthcare workers, patients, and a community care for each other.",1.0,1.0,1.0,1.0
Q6_A4,7,People's connection to the facility dog ultimately proved to be a critical factor in helping them connect with one another.,The relationship between people and the hospital dog was a key factor in helping them connect with one another.,1.0,1.0,1.0,1.0
Q7_A3,1,Background: To examine our initial experience in carotid stenting (CS) for the prevention of stroke in patients with high-grade carotid stenoses.,The goal of the study was to examine our first experience in carotid stenting (CS) to prevent strokes in patients with severe narrowing of blood vessels. Carotid stenting is a surgery where a tube is placed in a blood vessel to reduce narrowing.,1,1,1,1
Q7_A3,2,Methods: The authors performed 26 CS procedures in 25 carotid vessels in 22 patients over a 15-month period.,The authors did 26 CS surgeries in 25 blood vessels from 22 patients across 15 months.,1,1,1,1
Q7_A3,3,"All carotid stenoses treated, except one, were 70% or greater.","All narrowed blood vessels that were treated, except one, were 70% or greater.",0,1,1,0
Q7_A3,4,"Of all CS procedures, 84% were performed for obstructing atherosclerotic plaques.",84% of all CS surgeries were done to treat blocking due to plaque.,1,1,1,1
Q7_A3,5,"CS was performed in one patient each for carotid dissection and pseudoaneurysms caused by a gunshot wound, post-radiation stenosis, post-carotid endarterectomy (CEA) restenosis, and a flow-obstructing post-CEA intimal flap.",CS was done once per patient for a variety of blood vessel issues.,0,0,0,1
Q7_A3,6,"Of all patients, 68.2% were symptomatic, with a history of stroke or transient ischemic attacks ipsilateral to the treated carotid artery.","68.2% of patients had symptoms, with a history of strokes or temporary stroke-like attacks on the same side as the treated blood vessel.",1,1,1,1
Q7_A3,7,"In addition, 36.4% of our patients were either hospitalized or required skilled nursing care before CS because of severe neurologic deficits.","Also, 36.4% of patients were either hospitalized or needed skilled nursing care before CS due to brain defects.",1,1,-1,1
Q7_A3,8,"Using the Sundt CEA-risk classification system, 59.1% of our patients were classified as Grade III and 40.9% were Grade IV pre-CS.","Using a system called the ""Sundt CEA-risk classification system,"" 59.1% of patients were classified as Grade III and 40.9% were Grade IV before CS.",-1,0,0,1
Q7_A3,9,All but one patient had either a compelling medical or anatomic reason for endovascular treatment of their carotid disease.,Every patient except one either had an important medical or body reason for blood vessel surgery.,1,1,0,1
Q7_A3,10,"We used both Wallstents and Palmaz stents, and all procedures were performed via the transfemoral route.","We used two types of tubes, called Wallstents and Palmaz stents, and all surgeries were done using the femur as an entry point.",1,1,1,1
Q7_A3,11,"Three procedures were performed in conjunction with detachable platinum coil embolization for multiple carotid pseudoaneurysms, a residual carotid ""stump"" after previous ICA thrombosis, and an ipsilateral MCA saccular aneurysm.","Three surgeries were done along with another type of surgery for ""detachable platinum coil embolization.""",-1,-1,-1,1
Q7_A3,12,Results: We had a 96.2% procedural technical success rate.,We had a success rate of 96.2%.,1,1,1,1
Q7_A3,13,There was one death in our series 3 weeks post-CS attributable to myocardial infarction.,There was one death among our patients 3 weeks after CS due to a heart attack.,1,1,1,1
Q7_A3,14,"Despite a high 30-day combined death, stroke, and ipsilateral blindness rate of 27.3% (6/22 patients), only two ipsilateral strokes directly related to CS occurred (7.7% per procedures performed) from which one patient recovered fully within 5 days.","Despite a high rate of death, stroke, and blindness on the same side of the body as the surgery after 30 days (27.3%, or 6/22 patients), only two strokes that were directly related to CS occurred. One patient recovered from their stroke fully within 5 days.",0,0,0,1
Q7_A3,15,"The average follow-up post-CS was 5.9 months (range, 3 weeks-15 months).","The average follow-up post-CS was 5.9 months, and ranged between 3 weeks and 15 months.",0,0,0,1
Q7_A3,16,"Of successfully treated vessels, 58.3% have undergone 6-month follow-up vascular imaging, which has revealed a 14.3% rate of occlusion or restenosis greater than 50%.","Of the successfully treated vessels, 58.3% had follow-up x-rays after 6 months. The x-rays found a 14.3% rate of blockage or renarrowing more than 50%.",0,0,0,1
Q7_A3,17,"At or beyond 1 month post-CS, 19 of 21 surviving patients (90.5%) were ambulatory, fluent of speech, and independent, and none has thus far suffered a delayed stroke or TIA.","At or after 1 month post-CS, 19 of 21 living patients were able to walk, could talk, were independent, and none had a delayed stroke or a temporary stroke-like attack.",1,1,1,1
Q7_A3,18,Conclusion: CS seems to be a reasonable alternative to medical management for the treatment of carotid disease in patients deemed to be poor candidates for standard carotid surgery.,CS seems to be an acceptable alternate option for treating carotid disease in patients who should not have normal carotid surgery.,1,1,1,1
Q7_A3,19,Longer term follow-up is necessary to assess the durability of carotid revascularization using CS.,Longer term follow-up is needed to understand how long the treatment might last.,1,1,1,1
Q8_A1,1,"The frequency and severity of 17 side effects presumably associated with stimulant medication were assessed during a rigorous, triple-blind, placebo-controlled, crossover evaluation of methylphenidate, 0.3 and 0.5 mg/kg twice a day, in 83 children with attention deficit hyperactivity disorder.","We performed a study that looked at the effects of taking methylphenidate (a medication for ADHD) among children with attention deficit hyperactivity disorder (ADHD). We looked at 17 side effects that are commonly linked to stimulant medications (medications that make the central nervous system more active), like methylphenidate. Our study included 83 children who took dosages of 0.3 mg and 0.5 mg per kilogram of methylphenidate (a medication for ADHD) twice a day. In our study, neither the children, clinicians, nor the researcher knew if children were getting the medication or a placebo (a substance that doesn't affect the body, but given to some participants instead of the actual drug to compare and see the effectiveness of the actual drug). Additionally, children received both dosages but in random order.",0.0,1.0,1.0,1.0
Q8_A1,2,Side effects were rated by parents and teachers at the end of each weekly drug condition.,"At the end of every week, parents and teachers rated the side effects that the children experienced.",1.0,1.0,1.0,1.0
Q8_A1,3,Three children (3.6%) had side effects that were sufficiently serious to warrant immediate discontinuation of medication.,Three children (3.6%) had side effects that were serious enough to discontinue the medication immediately.,1.0,1.0,1.0,1.0
Q8_A1,4,"Parent ratings indicated that only the side effects of decreased appetite, insomnia, stomachaches, and headaches increased significantly in frequency and severity during the two active medication doses as compared with the placebo condition.","Compared to children who received a placebo, parents of children who were receiving the medication reported that side effects happened more often and got worse as time passed. Side effects included decreased appetite, insomnia (trouble sleeping), stomachaches, and headaches.",1.0,1.0,1.0,1.0
Q8_A1,5,"Fewer than half of the children experienced these side effects and among those who did, ratings of mean severity remained in the mild range.","Less than half of the children who received medication experienced these side effects. Among the children who did have side effects, ratings for the average severity were considered mild.",1.0,1.0,1.0,1.0
Q8_A1,6,"Teacher ratings showed little change over drug conditions, except on ratings of staring, sadness, and anxiety, which declined with increasing dose of medication.","Ratings of side effects from teachers for children who received the medication showed little change over time except for staring, sadness, and anxiety, which decreased with a higher doses of medication.",0.0,1.0,1.0,1.0
Q8_A1,7,"Parent ratings indicated that only the side effects of decreased appetite, insomnia, stomachaches, and headaches increased significantly in frequency and severity during the two active medication doses as compared with the placebo condition.","Compared to children who received a placebo, parents of children who were receiving the medication reported that side effects happened more often and got worse as time passed. Side effects included decreased appetite, insomnia (trouble sleeping), stomachaches, and headaches.",1.0,1.0,1.0,1.0
Q8_A1,8,"Fewer than half of the children experienced these side effects and among those who did, ratings of mean severity remained in the mild range.","Less than half of the children who received medication experienced these side effects. Among the children who did have side effects, ratings for the average severity were considered mild.",1.0,1.0,1.0,1.0
Q8_A1,9,"Teacher ratings showed little change over drug conditions, except on ratings of staring, sadness, and anxiety, which declined with increasing dose of medication.","Ratings of side effects from teachers for children who received the medication showed little change over time except for staring, sadness, and anxiety, which decreased with a higher doses of medication.",0.0,1.0,1.0,1.0
Q8_A1,10,"Surprisingly, a high frequency of these behavior side effects were reported during the placebo condition.","Surprisingly, behavioral side effects happened more often among children who received the placebo.",1.0,1.0,0.0,1.0
Q8_A1,11,"Stimulant medication within this therapeutic range, therefore, results in few, generally mild side effects.","In conclusion, stimulant medication at these dosages resulted in few, generally mild side effects.",1.0,-1.0,1.0,1.0
Q9_A8,1,Background and objectives: Probiotics have been widely used for host immune system enhancement but with limited knowledge regarding the immunomodulation mechanisms by which they assist the mucosal innate immune response.,"Probiotics have been widely used for immune system enhancement. However, there is limited knowledge on the ways they alter the innate immune system. The innate immune system if the response a person that is present from birth and is the body's first response to harmful agents.",0,1,0,0
Q9_A8,2,"We investigated the effects of probiotics on the modulation of the innate mucosal immune response particularly in association with Toll-like receptor (TLR)-2, TLR-4 and nuclear factor-kappa B (NF-κB) p65 and p105.","This study investigated the effects of probiotics on the alteration of the innate mucosal immune response. Specifically, they looked at the association with Toll-like receptor (TLR)-2, TLR-4, and nuclear factor-kappa B (NF-κB) p65 and p105. These are all factors of the immune system.",0,1,1,1
Q9_A8,3,Materials and methods: We randomized 24 male BALB/c mice into four groups.,The study used 24 male BALB/c mice and divided them into four groups.,0,0,0,1
Q9_A8,4,Two groups were administered probiotics for 21 consecutive days; one of these groups was challenged with Lipopolysaccharide (LPS) on day 15.,"Two groups were given probiotics for 21 consecutive days. One group was given Lipopolysaccharide (LPS), a component within the membrane of bacteria, on day 15.",0,1,1,1
Q9_A8,5,The third group was challenged with only LPS.,The third group was given only LPS.,1,1,1,1
Q9_A8,6,The fourth group remained untreated.,The fourth group was not treated.,1,1,1,1
Q9_A8,7,All mice were sacrificed after 21 days.,All mice were euthanized after 21 days.,0,0,0,0
Q9_A8,8,"An immunohistochemistry procedure on the ileum was performed and monoclonal antibodies specific for TLR-2, TLR-4 and NF-κB p65 and p105 were used for the analysis of innate lymphoid cells.","Analysis of the small intestine was done. Antibodies specific for TLR-2, TLR-4, and NF-κB p65 and p105 were used for the analysis of white blood cells within the immune system.",1,1,1,1
Q9_A8,9,"Results: In the LPS-only treated group, there was a significant decrease in p105, indicating an alternative transcription pathway for the process of pro-inflammatory cytokine production.","In the LPS-only treated group, there was a significant decrease in p105. This indicates a different pathway is being used for the production of pro-inflammatory cytokines (proteins that help carry signals through the body).",1,1,1,1
Q9_A8,10,In the probiotics-only treated group there was significant enhancement of TLR-2 and TLR-4 and NF-κB p65 and p105.,"In the probiotics-only treated group there was significant enhancement of TLR-2, TLR-4, NF-κB p65 and p105.",0,0,0,1
Q9_A8,11,"When mice treated with probiotics were exposed to LPS, there was a significant decrease in NF-κB p65 and p105, indicating employment of the classical pathway for pro-inflammatory cytokine production.","When mice treated with probiotics were exposed to LPS, there was a significant decrease in NF-κB p65 and p105. This shows use of the normal pathway for pro-inflammatory cytokine production.",0,1,1,1
Q9_A8,12,Conclusion: Probiotics can enhance the innate mucosal immune response in healthy mice and can maintain the homeostasis of the gut mucosal immune response against LPS through the activation of the classical NF-κB pathway.,"Probiotics can enhance the innate mucosal immune response in healthy mice. Probiotics can maintain the stability of the gut mucosal immune response against LPS by activating the normal NF-κB pathway, which receives signals of harmful agents and then deploys a response to reduce danger.",1,1,1,1
Q10_A9,1,"Objective: Does short-term cryotherapy improve pain, function and quality of life in people with knee osteoarthritis (OA)?","This study hoped to determine if short-term cryotherapy improves pain, function and quality of life in people with knee osteoarthritis. Osteoarthritis is a degenerative, or deteriorating, joint disease.",1,0,1,1
Q10_A9,2,"Design: Randomised controlled trial with concealed allocation, blinded assessment of some outcomes, and intention-to-treat analysis.",This was a trail with high study quality and good methodology.,1,1,1,1
Q10_A9,3,Participants: People living in the community with knee OA.,This study focused on people living in the community with knee OA.,1,1,1,1
Q10_A9,4,"Interventions: The experimental group received cryotherapy, delivered as packs of crushed ice applied to the knee with mild compression.",The experimental group received cryotherapy via packs of crushed ice applied to the knee with mild compression.,1,0,1,1
Q10_A9,5,The control group received the same regimen but with sham packs filled with sand.,"The control group received the same regimen but with ""false"" packs filled with sand.",1,1,1,1
Q10_A9,6,The interventions were applied once a day for 4 consecutive days.,The treatments were applied once a day for 4 consecutive days.,1,1,1,1
Q10_A9,7,Outcome measures: Participants were assessed at baseline and on the day after the 4-day intervention period.,Participants were assessed at before the study started and on the day after the 4-day intervention period.,1,0,1,1
Q10_A9,8,The primary outcome was pain intensity according to a visual analogue scale.,The primary outcome measured was pain intensity.,1,1,1,1
Q10_A9,9,"Secondary outcomes were baseline to post-intervention changes according to the Western Ontario and McMaster Universities Osteoarthritis, Knee injury and Osteoarthritis Outcome; Timed Up and Go test; and 30-Second Chair to Stand test.","Secondary outcomes included specific tests to determine disease extensiveness and ability to stand, move, and sit with ease.",1,1,1,1
Q10_A9,10,Results: Sixty participants were randomised into the experimental group (n = 30) or the control group (n = 30).,Sixty participants were put into either the experimental or the control group.,1,1,1,1
Q10_A9,11,Twenty-nine participants from each group completed the trial.,Twenty-nine participants from each group completed the trial.,1,1,1,1
Q10_A9,12,"The mean between-group difference in change in pain severity was -0.8 cm (95% CI -1.6 to 0.1), where negative values favour the experimental group.",The experimental group had the greatest change in pain severity.,1,1,1,1
Q10_A9,13,This result did not reach the nominated smallest worthwhile effect of 1.75 cm.,However the change in pain severity was not significant.,1,1,1,1
Q10_A9,14,"The secondary outcomes had less-precise estimates, with confidence intervals that spanned worthwhile, trivial and mildly harmful effects.",The secondary outcomes had less-precise estimates.,1,1,1,1
Q10_A9,15,Conclusion: Short-term cryotherapy was not superior to a sham intervention in terms of relieving pain or improving function and quality of life in people with knee OA.,"Short-term cryotherapy was not better than ""false"" packs in relieving pain or improving function and quality of life in people with knee OA.",1,1,1,1
Q10_A9,16,"Although cryotherapy is considered to be a widely used resource in clinical practice, this study does not suggest that it has an important short-term effect, when compared with a sham control, as a non-pharmacological treatment for people with knee osteoarthritis.","Although cryotherapy is considered to be a widely used resource in clinical practice, this study does not suggest that it has an important short-term effect as a non-medicinal way to treat knee OA.",0,0,1,1
Q11_A1,1,The evidence of long-term clinical dynamic on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA re-positive case are less.,The research of long-term clinical changes on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA re-positive case (when a person tests negative consecutively and then retests positive for the same infection) are limited.,1.0,1.0,1.0,1.0
Q11_A1,2,"We performed a 108 days follow-up on dynamic clinical presentations in a case, who hospitalized three times due to the positive recurrence of SARS-CoV-2 RNA after discharge, to understand the prognosis of the 2019-Coronavirus disease (COVID-19).","We studied a case for a 108 day follow-up on changing clinical presentations to understand the outlook of the 2019-Coronavirus disease (COVID-19). In this case, the person was hospitalized 3 times due to the positive recurrence of SARS-CoV-2 after hospital discharge.",0.0,0.0,1.0,1.0
Q11_A1,3,"In this case, positive SARS-CoV-2 recurred even after apparent recovery (normal CT imaging, no clinical symptoms, negative SARS-CoV-2 on stool sample and negative serum IgM test) from COVID-19, viral shedding duration lasted for 65 days, the time from symptom onset to disappearance was up to 95 days.","Positive SARS-CoV-2 recurred even after the patient seemed to recover from COVID-19 (normal radiology finding, no symptoms, negative SARS-CoV-2 on stool sample, and negative blood test). Viral shedding (the release of copies of a virus from the body) lasted for 65 days. The time from the start of symptoms to disappearance was up to 95 days.",1.0,1.0,1.0,1.0
Q11_A1,4,"Erythrocyte-associated indicators, liver function and serum lipid metabolism presented abnormal throughout during the observation period.","White blood cell indicators, liver function and fat metabolism were abnormal throughout the observation period.",1.0,1.0,1.0,1.0
Q11_A1,5,Awareness of atypical presentations such as this one is important to prompt the improvement of the management of COVID-19.,Awareness of out of the ordinary presentations are important to improve the management of COVID-19.,1.0,1.0,1.0,1.0
Q12_A2,1,"The use of oral terbinafine in the treatment of superficial dermatophyte infections has been extensively studied, using different treatment regimens.","The use of terbinafine (a type of antifungal pill) in the treatment of superficial dermatophyte infections, or fungal infections on or near the surface of the skin,  has been deeply studied using  a variety of treatments.",-1.0,1.0,1.0,1.0
Q12_A2,2,"To evaluate the efficacy of short-term therapy with oral terbinafine in cases of tinea cruris/corporis, 22 patients (21 male and one female) with mycologically proven tinea cruris/corporis, were included in the present study.",We studied the effectiveness of short-term treatment with terbinafine pill in 22 patient cases (21 male and 1 female) with laboratory-confirmed jock itch or ringworm.,1.0,1.0,1.0,0.0
Q12_A2,3,Each patient received one tablet of terbinafine 250 mg daily for 1 week.,"Each patient received a single 250mg terbinafine pill per day, for 1 week.",1.0,1.0,1.0,1.0
Q12_A2,4,Patients were followed-up for 6 weeks after completion of treatment.,Patients were followed for 6 weeks after finishing treatment.,1.0,1.0,1.0,1.0
Q12_A2,5,"Clinical and mycological assessments were performed at the end of treatment, and at the end of the follow-up period.","Clinical and fungus tests were performed at the end of treatment, and at the end of the follow-up period.",1.0,1.0,1.0,1.0
Q12_A2,6,"The mean sum of scores of signs and symptoms in all patients decreased significantly from 12.36 before treatment to 0 at the end of the follow-up period, and mycological investigations were negative in all patients at the end of the follow-up period.",The average sum of scores of signs and symptoms in all patients decreased significantly from 12.36 before treatment to 0 at the end of the follow-up period. Fungus tests were negative in all patients at the end of the follow-up period.,1.0,1.0,1.0,1.0
Q12_A2,7,Our results show that 1-week therapy with oral terbinafine is highly effective in the treatment of tinea cruris/corporis.,We found that 1-week therapy with terbinafine pills is highly effective in the treatment of jock itch and ringworm infections.,1.0,1.0,1.0,1.0
Q13_A7,1,Abdominal aortic aneurysm (AAA) is defined as a permanent dilatation of the abdominal aorta that exceeds 3 cm.,"The abdominal aorta is the largest blood vessel in the body and runs through the middle of the torso area. An aneurysm is a bulge in a blood vessel caused by a weakness in the blood vessel wall, usually where it branches. Abdominal aortic aneurysm (AAA) is a permanent growth of the abdominal aorta that is over 3 cm.",1.0,1.0,0.0,1.0
Q13_A7,2,Most AAAs arise in the portion of abdominal aorta distal to the renal arteries and are defined as infrarenal.,Most AAAs arise in the part of the abdominal aorta far from the kidney arteries and are defined as infrarenal.,1.0,1.0,0.0,1.0
Q13_A7,3,Most AAAs are totally asymptomatic until catastrophic rupture.,"Most AAAs are totally not symptomatic until catastrophic rupture, or breaking open of the artery.",1.0,1.0,1.0,1.0
Q13_A7,4,The strongest predictor of AAA rupture is the diameter.,The strongest risk factor of AAA rupture is the width.,1.0,1.0,1.0,1.0
Q13_A7,5,Surgery is indicated to prevent rupture when the risk of rupture exceeds the risk of surgery.,Surgery is recommended to prevent rupture when the risk of rupture is more than the risk of surgery.,1.0,1.0,1.0,1.0
Q13_A7,6,"In this review, we aim to analyze this disease comprehensively, starting from an epidemiological perspective, exploring etiology and pathophysiology, and concluding with surgical controversies.",We aimed to look at AAA in detail.,1.0,0.0,0.0,1.0
Q13_A7,7,We will pursue these goals by addressing eight specific questions regarding AAA: (1) Is the incidence of AAA increasing? (2) Are ultrasound screening programs for AAA effective? (3) What causes AAA: Genes versus environment? (4) Animal models: Are they really relevant? (5) What pathophysiology leads to AAA? (6) Indications for AAA surgery: Are surgeons over-eager to operate? (7) Elective AAA repair: Open or endovascular? (8) Emergency AAA repair: Open or endovascular?,"We addressed 8 specific questions regarding AAA: (1) Is the occurrence, rate, or frequency of AAA increasing? (2) Are ultrasound screening programs for AAA effective? (3) What causes AAA, genes versus environment? (4) Are animal models really relevant? (5) What physical disease process leads to AAA? (6) Are surgeons over-eager to operate? (7) Scheduled open AAA repair or endovascular? (8) Emergency AAA repair, open or endovascular? Open surgery repair is the traditional type of surgery in which the cutting of skin and tissues is completed so the surgeon has a full view of the structures or organs. Endovascular surgery is performed inside the aorta using thin, long tubes called catheters to place a stent, or a device that opens an artery, surrounded with a fabric liner to strengthen the weak spots.",1.0,1.0,1.0,1.0
Q14_A1,1,"Idiopathic pulmonary fibrosis (IPF) is an incurable condition that is characterized by progressive pulmonary fibrosis, architectural distortion of the lung and loss of gas exchange units.",Idiopathic pulmonary fibrosis (IPF) is a condition that has no cure. It's described as the worsening of scarring in the lungs as well as the loss of the ability for the lungs to get enough oxygen.,1.0,1.0,1.0,1.0
Q14_A1,2,"Until recently, there was no effective treatment for this condition.","Until recently, there was no effective treatment for IPF.",1.0,1.0,1.0,1.0
Q14_A1,3,"However, there were two landmark trials published earlier this year, which have changed the management of this condition.","However, findings from two groundbreaking clinical trials published earlier this year have changed the way IPF can be managed.",1.0,1.0,1.0,1.0
Q14_A1,4,Pirfenidone (Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis trial) and nintedanib (Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis-1 and -2 trials) have both demonstrated positive outcomes in patients with IPF.,Pirfenidone and nintedanib are two therapeutic drugs that have both showed positive outcomes in patients with IPF.,1.0,1.0,1.0,1.0
Q14_A1,5,"In this perspective, we critically discuss the role of these agents in IPF and in the broader pulmonary fibrosis population.",We discuss the role of these drugs in IPF and in the broader lung disease population.,1.0,1.0,1.0,1.0
Q15_A1,1,"Objectives: We compared the semiquantitative measurement of acetoacetate using urinary dipsticks with the bedside quantitative fingerprick measurement of the principal ketone bodies 3-beta-hydroxybutyrate, for the diagnosis of ketoacidosis.","We compared the measurement of chemicals called ""ketones"" in urine with the measurement of ketones in blood to see which is more useful in diagnosing a disease called ketoacidosis.",1,0,1,1
Q15_A1,2,Methods: This is a one year retrospective study of patients who presented with hyperglycemia levels of 250 mg/l or greater in the Emergency Department setting.,This is a one-year study of patients who came to our Emergency Department with high blood sugar levels of 250 milligrams per liter or more.,1,1,1,1
Q15_A1,3,"We compared the sensitivity, specificity, and predictive value of ketonuria and ketonemia for the diagnosis of ketoacidosis (urine or blood ketone bodies, blood bicarbonates <20 mmol/l, anion gap >16 meq/l) in a sample of patients for whom the levels of ketone bodies in the blood and urine as well as serum electrolytes were available.",We compared several statistical measures of ketones in blood or urine for their ability to predict the diagnosis of ketoacidosis.,1,1,1,1
Q15_A1,4,Results: We studied 355 hyperglycemic patients.,We studied 355 patients with high blood sugar.,1,1,1,1
Q15_A1,6,Comparison between ketonuria and ketonemia was performed in 173 patients (6% with diabetic ketoacidosis).,"Comparison between blood ketones and urine ketones was done in 173 patients, 6% with diabetic ketoacidosis.",0,1,1,1
Q15_A1,7,Ketonuria equal to or less than one cross or a 3-beta-hydroxybutyrate value lower than 3 mmol/l enabled ketoacidosis to be excluded (negative predictive value 100%).,Low values of ketones in blood or urine meant that ketoacidosis was confirmed not to be diagnosed.,0,1,1,1
Q15_A1,8,"At two-cross cutoff points for ketonuria and at the 3 mmol/l cutoff point for ketonemia, the two tests had the same sensitivity (100%), but the specificity of 3-beta-hydroxybutyrate (94%) was significantly higher (P<0.0001) than that of ketonuria (77%).","Most statistical measures were similar between urine and blood ketones. However, blood ketones were more likely to accurately identify patients who were confirmed to not have ketoacidosis.",1,1,1,1
Q15_A1,10,"At the three-cross cutoff point for ketonuria and at the 5 mmol/l cutoff point for ketonemia, the two tests had the same negative likelihood ratio (0.1), but the positive likelihood ratio of 3-beta-hydroxybutyrate (infinite) was higher than that of ketonuria.",Results favored blood ketone measures in predicting ketoacidosis.,1,0,1,1
Q15_A1,11,Conclusion: The measurement of 3-beta-hydroxybutyrate in capillary blood is faster and more effective than the use of dipsticks in the urine to detect ketoacidosis in the Emergency Department setting.,The measurement of blood ketones is faster and more effective than using urine ketones to diagnose ketoacidosis in Emergency Departments.,1,1,1,1
Q16_A2,1,Factors other than the glomerular filtration rate (GFR) can affect creatinine clearance (Ccr) and serum creatinine concentration (Pcr).,"Many things, other than glomerular filtration rate (GFR), can affect creatinine clearance (Ccr) and serum creatinine concentration (Pcr). GFR is a test often done to determine if the kidneys are working properly. Creatinine is a byproduct of creatine breakdown which supplies energy for muscle contraction. Creatinine is filtered from the blood by the kidneys and is often used to determine kidney function.",1,1,1,1
Q16_A2,2,The effect of dietary protein and antihypertensive therapy on Ccr the reciprocal of the Pcr (1/Pcr).,"This study assessed patients with kidney disease that were trying altered diets. Specifically, this study looked at the effect dietary protein and antihypertensive therapy had on Ccr the reciprocal of the Pcr (1/Pcr), GFR, creatinine clearance from tubular secretion (CTScr), and creatinine excretion (UcrV) values. Antihypertensive therapy is done to reduce blood pressure.",1,1,1,1
Q16_A2,4,This study compared the effects of assignment to a low versus usual-protein diet and to a low versus usual-blood pressure goal on the decline in these measurements over 3 yr in 585 patients with baseline GFR of 25 to 55 mL/min per 1.73 m2 (Study A).,"This report conducted two different studies: Study A and Study B. In Study A, the authors looked at 585 patients with GFR of 25 to 55 mL/min per 1.73 m2. In these patients, the effects of a low versus usual-protein diet and a low versus usual-blood pressure goal on the decline was determined over three years.",1,1,1,1
Q16_A2,5,"This study also assessed correlations and associations of these measurements with each other and with protein intake, blood pressure, class of antihypertensive agents, and renal diagnosis in 840 patients with baseline GFR of 13 to 55 mL/min per 1.73 m2 (Studies A and B).","In Study B, the authors looked at 840 patients with GFR of 13 to 55 mL/min per 1.73 m2. In these patients, the same endpoints as Study A were assessed. However, these endpoints were also linked with each other, protein intake, blood pressure, class of antihypertensive agents, and kidney health.",1,1,1,1
Q16_A2,6,"In Study A, the estimated mean decline in GFR at 3 yr did not differ significantly between the low and usual-protein diet groups (-10.9 versus -12.1 mL/min).","In Study A, the decline in GFR at 3 years was unchanged between the low and usual-protein diet groups.",1,1,1,1
Q16_A2,7,"In contrast, CTScr declined more in the low-protein diet group (-7.8 versus -3.6 mL/min, P < .05).","In contrast, CTScr (a creatinine in blood filtration test) declined more in the low-protein diet group.",1,1,1,1
Q16_A2,8,"Consequently, the low-protein diet group had a greater decline in Ccr (-17.6 versus -14.4 mL/min, P < .05).",The low-protein diet group had a greater decline in Ccr as well.,1,1,1,1
Q16_A2,9,"The low-protein diet group also had a greater decline in UcrV (-306 versus -92 mg/day, P < .05).",The low-protein diet group also had a greater decline in UcrV (removal of creatinine from the entire body).,1,1,1,1
Q16_A2,10,"The decline in UcrV was proportionately greater than the decline in CTScr hence the decline in 1/Pcr was less in the low-protein diet group (-0.091 versus -0.122 dl/mg, P < .05).","UcrV declined more CTScr. Therefore, the decline in 1/Pcr (creatinine clearance divided by serum creatinine concentration) was less in the low-protein diet group.",1,1,0,1
Q16_A2,11,"Similarly, in Study A, there was no significant difference in the decline in GFR at 3 yr between the low and usual-blood pressure groups (-10.7 versus -12.3 mL/ min).","In Study A, GFR did not drastically change at 3 years between the low and usual-blood pressure groups.",1,1,1,1
Q16_A2,12,"However, there was a lesser decline in CTScr in the low blood pressure group (-4.7 versus -6.7 mL/ min, P < .05).","However, CTScr decreased less in the low blood pressure group.",1,1,1,1
Q16_A2,13,"Consequently, the decline in Ccr was less in the low blood pressure group (-14.2 versus -17.8 mL/min, P < .05).","Consequently, the decline in Ccr was less in the low blood pressure group.",1,1,1,1
Q16_A2,14,There was no significant difference in UcrV between the blood pressure groups (-192 versus -205 mg/day).,There was no major difference in UcrV between the blood pressure groups.,1,1,1,1
Q16_A2,15,"Hence, the decline in 1/Pcr paralleled the decline in Ccr; it was less in the low blood pressure group (-0.091 versus -0.122 dL/mg, P < .05).","Hence, the decline in 1/Pcr was similar to the decline in Ccr; it was less in the low blood pressure group.",1,1,1,1
Q16_A2,16,"In Studies A and B, correlations of rates of decline in Ccr and GFR were 0.64 and 0.79, respectively (P < 0.001).","In Studies A and B, correlations between the declines in Ccr and GFR were similar.",1,1,0,1
Q16_A2,17,"Correlations of rates of decline in 1/Pcr and GFR were 0.79 and 0.85, respectively (P < 0.001).",Correlations between the declines in 1/Pcr and GFR were also similar.,1,0,0,1
Q16_A2,18,"In Studies A and B combined, baseline GFR, CTScr and UcrV correlated significantly with protein intake (r = 0.45, 0.47, and 0.36, respectively; P < 0.001), but not with blood pressure.","In Studies A and B combined, GFR, CTScr and UcrV at the start of the study were linked significantly with protein intake; however, they were not linked with blood pressure.",1,1,1,1
Q16_A2,19,"Baseline CTScr was significantly lower in patients with polycystic kidney disease and tubulointerstitial diseases or urinary tract diseases, compared with glomerular and other diseases (P < 0.05).","CTScr before the study was much lower in patients with polycystic kidney disease, tubulointerstitial diseases, and urinary tract diseases when compared to patients with glomerular and other diseases.",0,0,1,1
Q16_A2,20,"It was also lower in patients who were taking calcium channel blockers, compared with patients not taking these agents, and in patients not taking diuretics, compared with patients taking diuretics (P < 0.05).",CTScr was also lower in patients who were taking medicine to lower blood pressure when compared to patients not taking these medicine. CTScr was lower in patients not taking diuretics (medicine to reduce body salt and water) when compared to patients taking diuretics.,1,1,1,0
Q16_A2,21,These results show that creatinine secretion and excretion are affected by protein intake.,These results show that creatinine processing and total removal from the body are affected by protein intake.,1,1,1,1
Q16_A2,22,Creatinine secretion is also affected by antihypertensive therapy and renal diagnosis.,Creatinine secretion is also affected by antihypertensive therapy and kidney health.,1,0,1,1
Q16_A2,23,"In the MDRD Study, the low-protein diet reduced creatinine secretion and excretion, and the low blood pressure goal slowed the decline in creatinine secretion.","In the this study, the low-protein diet reduced creatinine processing and total removal from the body. Additionally, the low blood pressure goal slowed the decline in creatinine release within the body.",1,1,1,1
Q16_A2,24,These effects caused differences between the diet groups and between the blood pressure groups in Ccr and 1/Pcr that were not the result of differences in GFR.,These effects caused differences between the diet groups and between the blood pressure groups in Ccr and 1/Pcr. These difference cannot be attributed to differences in GFR.,1,1,1,1
Q16_A2,25,Studies assessing the effects of these interventions on the progression of renal disease should measure GFR in addition to Ccr and Pcr.,"Studies assessing the effects of these interventions on the progression of kidney disease should measure GFR, Ccr, and Pcr.",1,0,1,1
Q17_A4,1,The realization that low-glycemic index diets were formulated using resistant starch led to more than a decade of research on the health effects of resistant starch.,"Low-glycemic index diets, or eating habits that affect blood sugar levels, were based on using resistant starches. This discovery led to over a decade of research on the health effects of resistant starch.",1.0,1.0,1.0,1.0
Q17_A4,2,Determination of the metabolizable energy of the resistant starch product allowed for the performance of isocaloric studies.,Defining the metabolizable energy of resistant starch products allowed for isocaloric (same calorie value) studies to be conducted.,0.0,0.0,1.0,1.0
Q17_A4,3,"Fermentation of resistant starch in rodent studies results in what appears to be a healthier gut, demonstrated by increased amounts of short-chain fatty acids, an apparent positive change in the microbiota, and increased gene expression for gene products involved in normal healthy proliferation and apoptosis of potential cancer cells.","Rodent studies showed that fermentation of resistant starch resulted in better gut health. This was shown by increased short-chain fatty acids, a byproduct of fiber digestion. This is a positive change in the gut environment. Furthermore, these studies showed increased expression of genes involved in healthy division and death of potential cancer cells.",1.0,0.0,1.0,1.0
Q17_A4,4,"Additionally, consumption of resistant starch was associated with reduced abdominal fat and improved insulin sensitivity.","Additionally, eating resistant starch was linked with reduced abdominal fat and improved insulin sensitivity.",0.0,0.0,0.0,1.0
Q17_A4,5,Increased serum glucagon-like peptide 1 (GLP-1) likely plays a role in promoting these health benefits.,"Increased serum glucagon-like peptide 1 (GLP-1), a molecule in the gut released after eating, likely helps promote these health benefits.",1.0,1.0,0.0,1.0
Q17_A4,6,One rodent study that did not use isocaloric diets demonstrated that the use of resistant starch at 8% of the weight of the diet reduced body fat.,A rodent study showed that the use of resistant starch at 8% of the weight of the diet reduced body fat.,1.0,1.0,1.0,1.0
Q17_A4,7,This appears to be approximately equivalent to the human fiber requirement.,This is approximately equal to the human fiber requirement.,1.0,1.0,1.0,1.0
Q17_A4,8,"In human subjects, insulin sensitivity is increased with the feeding of resistant starch.","In humans, insulin sensitivity is increased with the feeding of resistant starch.",1.0,1.0,1.0,1.0
Q17_A4,9,"However, only 1 of several studies reports an increase in serum GLP-1 associated with resistant starch added to the diet.","However, only one study reported increased serum GLP-1 associated with resistant starch-increased diet.",1.0,1.0,1.0,1.0
Q17_A4,10,"This means that other mechanisms, such as increased intestinal gluconeogenesis or increased adiponectin, may be involved in the promotion of improved insulin sensitivity.",This means that other body functions may be involved in promoting improved insulin sensitivity.,1.0,1.0,1.0,1.0
Q17_A4,11,Future research may confirm that there will be improved health if human individuals consume the requirement for dietary fiber and a large amount of the fiber is fermentable.,Future research may show that eating the right amount of dietary fiber improves health and a large amount of the fiber is fermentable.,1.0,1.0,1.0,1.0
Q18_A2,1,Background: The current experiment investigated the impact of two potential confounding variables on the postural balance in young participants: the induced-experimental activity prior to the static postural measurements and the well-documented time-of-day effects.,This study investigated two variables that may influence posture balance in young participants. These variables include (1) activity prior to stand-still posture measurements and (2) changes based on time of day.,1.0,0.0,1.0,1.0
Q18_A2,2,We mainly hypothesized that an exhaustive exercise and a high attention-demanding task should result in alterations of postural control.,We mainly hypothesized that an tiring exercise and a high attention-demanding task should result in changes in posture control.,1.0,1.0,1.0,0.0
Q18_A2,3,"Methods: Ten participants performed three experimental sessions (differentiated by the activity - none, cognitive or physical - prior of the assessment of postural stability), separated by one day at least.","Ten people performed three experimental sessions before posture control was measured. Each session was separated by one day at least. The sessions were different based on activity: none, cognitive (mind), or physical (body).",1.0,1.0,1.0,1.0
Q18_A2,4,"Each session included postural balance assessments around 8 a.m., 12.00 p.m. and 5 p.m. ± 30 min.","Each session included postural balance assessments roughly around 8 a.m., 12.00 p.m., and 5 p.m..",1.0,0.0,1.0,1.0
Q18_A2,5,The physical and cognitive activities were performed only before the 12 o'clock assessment.,Mind and body activities were performed only before the 12 p.m. assessment.,1.0,1.0,1.0,1.0
Q18_A2,6,The postural tests consisted of four conditions of quiet stance: stance on a firm surface with eyes open; stance on a firm surface with eyes closed; stance on a foam surface with eyes open and stance on a foam surface with eyes closed.,The postural tests consisted of four conditions of quiet stance: stance on a firm surface with eyes open; stance on a firm surface with eyes closed; stance on a foam surface with eyes open; and stance on a foam surface with eyes closed.,0.0,0.0,1.0,1.0
Q18_A2,7,Postural performance was assessed by various center of pressure (COP) parameters.,"Posture was assessed by various center of pressure (COP), where the total sum of pressure field acts on the body.",0.0,1.0,0.0,1.0
Q18_A2,8,"Results: Overall, the COP findings indicated activity-related postural impairment, with an increase in body sway in the most difficult conditions (with foam surface), especially when postural measurements are recorded just after the running exercise (physical session) or the psychomotor vigilance test (cognitive session).",COP data showed posture impaired by activity. Body swaying increased in difficult conditions (foam surface). This was found especially when postural measurements are recorded just after running (body) or the psychomotor vigilance test (mind).,1.0,1.0,1.0,1.0
Q18_A2,9,"Conclusions: Even if no specific influence of time-of-day on static postural control is demonstrated, our results clearly suggest that the activities prior to balance tests could be a potential confounding variable to be taken into account and controlled when assessing clinical postural balance.","No specific influence of time-of-day on posture control when a pose is maintained. Yet, these results suggest that activities prior to balance tests could be influential. This should be taken into account and controlled when assessing clinical postural balance.",1.0,0.0,1.0,0.0
Q19_A9,1,"Lennox-Gastaut syndrome (LGS), a childhood-onset severe developmental and epileptic encephalopathy (DEE), is an entity that encompasses a heterogenous group of aetiologies, with no single genetic cause.","Lennox-Gastaut syndrome (LGS) is a severe developmental and epileptic encephalopathy (DEE; a disease of the brain) that begins in childhood. It is a disorder that includes several different causes, with no single genetic cause.",1.0,1.0,1.0,1.0
Q19_A9,2,"It is characterised by multiple seizure types, an abnormal EEG with generalised slow spike and wave discharges and cognitive impairment, associated with high morbidity and profound effects on the quality of life of patients and their families.","It is characterized by multiple seizure types, irregular brain activity and cognitive impairment. It is linked with high occurrence rates and significant effects on life and families.",1.0,1.0,1.0,1.0
Q19_A9,3,"Drug-refractory seizures are a hallmark and treatment is further complicated by its multiple morbidities, which evolve over the patient's lifetime.","Drug-refractory seizures, or seizures that persist despite medicine, are common of LGS. Treatment is complicated by its multiple side effect of the disease, which evolve over the patient's lifetime.",1.0,1.0,1.0,1.0
Q19_A9,4,This review provides a comprehensive overview of the current and future options for the treatment of seizures associated with LGS.,This review provides a thorough overview of the current and future treatment options for LGS seizures.,1.0,1.0,1.0,1.0
Q19_A9,5,"Six treatments are specifically indicated as adjunct therapies for the treatment of seizures associated with LGS in the US: lamotrigine, clobazam, rufinamide, topiramate, felbamate and most recently cannabidiol.","Six medicines have been pinpointed as supplementary therapies for LGS seizure treatment in the US: lamotrigine, clobazam, rufinamide, topiramate, felbamate, and most recently cannabidiol.",1.0,1.0,1.0,1.0
Q19_A9,6,"These therapies have demonstrated reductions in drop seizures in 15%-68% of patients across trials, with responder rates (≥ 50% reduction in drop seizures) of 37%-78%.","These therapies reduced drop seizures in 15-68% of patients across trials, with most patients having half or more drop seizures reduced.",1.0,1.0,1.0,1.0
Q19_A9,7,"Valproate is still the preferred first-line treatment, generally in combination with lamotrigine or clobazam.","Valproate is the preferred first-line treatment, generally in combination with lamotrigine or clobazam.",1.0,1.0,1.0,1.0
Q19_A9,8,"Other treatments frequently used off-label include the broad spectrum anti-epileptic drugs (AED) levetiracetam, zonisamide and perampanel, while recent evidence from observational studies has indicated that a newer AED, the levetiracetam analogue brivaracetam, may be effective and well tolerated in LGS patients.","There are several off-label treatments (used beyond their initial medicinal purpose) available. Recent study evidence has shown that a newer anti-epileptic drug, known as brivaracetam, may be helpful in LGS patients.",1.0,1.0,1.0,1.0
Q19_A9,9,"Other treatments in clinical development include fenfluramine in late phase III, perampanel, soticlestat-OV953/TAK-953, carisbamate and ganaxolone.",Other treatments are in clinical development phases.,1.0,1.0,1.0,1.0
Q19_A9,10,"Non-pharmacologic interventions include the ketogenic diet, vagus nerve stimulation and surgical interventions; these are also expanding, with the potential for less invasive techniques for corpus callosotomy that have promise for reducing complications.","There are non-pharmacologic interventions such as the keto diet, nerve stimulation, and surgery. Surgical options are expanding for less invasive techniques for seizure relief.",1.0,1.0,1.0,1.0
Q19_A9,11,"However, despite these advancements, patients continue to experience a significant burden.","However, despite these advancements, patients continue to experience a significant burden.",1.0,1.0,1.0,1.0
Q19_A9,12,"Because LGS is not a single entity, tailoring of treatment is needed as opposed to a 'one size fits all' approach.","Because LGS is not a single disease, specialization of treatment is needed as opposed to a 'one size fits all' approach.",1.0,1.0,1.0,1.0
Q19_A9,13,"Further research is needed into the underlying aetiologies and pathophysiology of LGS, together with advancements in treatments that encompass the spectrum of seizures associated with this complex syndrome.","Further research is needed to identify causes and mechanisms of LGS, along with advancements in treatments that include all types of seizes associated with LGS.",1.0,1.0,1.0,1.0
Q20_A7,1,"Laron syndrome (LS), or primary growth hormone resistance, is a prototypical congenital insulin-like growth factor 1 (IGF1) deficiency.","Laron syndrome (LS) is a genetic condition caused by variants, or changes, in the growth hormone receptor (GHR) gene. More specifically, LS is an insulin-like growth factor 1 (IGF1) deficiency that some people are born with (congenital).",1.0,1.0,1.0,1.0
Q20_A7,2,The recent epidemiological finding that LS patients do not develop cancer is of major scientific and clinical relevance.,The recent finding that LS patients do not develop cancer is of major scientific and clinical importance.,1.0,1.0,1.0,1.0
Q20_A7,3,Epidemiological data suggest that congenital IGF1 deficiency confers protection against the development of malignancies.,Data suggest that congenital IGF1 deficiency provides protection against the development of cancer.,1.0,0.0,1.0,1.0
Q20_A7,4,This 'experiment of nature' reflects the critical role of IGF1 in tumor biology.,This 'experiment of nature' reflects the critical role of IGF1 in tumor biology.,1.0,1.0,1.0,1.0
Q20_A7,5,The present review article provides an overview of recently conducted genome-wide profiling analyses aimed at identifying mechanisms and signaling pathways that are directly responsible for the link between life-time low IGF1 levels and protection from tumor development.,We provided an overview of recent research studies aimed at finding processes that are directly responsible for the link between life-time low IGF1 levels and protection from tumor development.,0.0,1.0,1.0,1.0
Q20_A7,6,The review underscores the concept that 'data mining' an orphan disease might translate into new developments in oncology.,"The review supports finding unusual outliers, patterns, and relationships within a large data set in a disease like LS might translate into new developments in oncology.",0.0,1.0,1.0,1.0
Q21_A8,1,"Peripheral neuropathies are characterized by nerves damage and axonal loss, and they could be classified in hereditary or acquired forms.","Peripheral neuropathies are when damage happens to the nerves or nervous system, and can be inherited or acquired throughout life.",1,0,1,1
Q21_A8,2,"Acquired peripheral neuropathies are associated with several causes, including toxic agent exposure, among which the antineoplastic compounds are responsible for the so called Chemotherapy-Induced Peripheral Neuropathy (CIPN).","Acquired peripheral neuropathies are associated with several causes. One cause includes exposure to a toxic agent, including chemotherapy, which can cause Chemotherapy-Induced Peripheral Neuropathy (CIPN).",1,0,1,1
Q21_A8,3,Several clinical features are related to the use of anticancer drugs which exert their action by affecting different mechanisms and structures of the peripheral nervous system: the axons (axonopathy) or the dorsal root ganglia (DRG) neurons cell body (neuronopathy/ganglionopathy).,"Chemotherapy drugs take action that impact many different structures of the peripheral nervous system, or the nervous system outside of the brain and spinal cord. These structures include the axons (axonopathy) or the dorsal root ganglia (DRG) neurons cell body (neuronopathy/ganglionopathy).",0,0,1,1
Q21_A8,4,"In addition, antineoplastic treatments may affect the blood brain barrier integrity, leading to cognitive impairment that may be severe and long-lasting.","In addition, chemotherapy treatments may affect the blood brain barrier, leading to cognitive impairment that may be severe and long-lasting.",0,0,0,1
Q21_A8,5,CIPN may affect patient quality of life leading to modification or discontinuation of the anticancer therapy.,CIPN may affect patient quality of life leading to changes or stopping anticancer therapy.,1,1,1,1
Q21_A8,6,"Although the mechanisms of the damage are not completely understood, several hypotheses have been proposed, among which neuroinflammation is now emerging to be relevant in CIPN pathophysiology.","Although the causes of damage CIPN are not completely understood, several theories have been proposed. One emerging theory in CIPN causes is neuroinflammation, or swelling of the nervous system.",0,1,0,0
Q21_A8,7,"In this review, we consider different aspects of neuro-immune interactions in several CIPN preclinical studies which suggest a critical connection between chemotherapeutic agents and neurotoxicity.",We looked at different nervous and immune system interactions in several CIPN research studies. These studies suggest an important connection between chemotherapy and neurotoxicity. Neurotoxicity is the amount or degree of a substance needed to be poisonous to the brain or nervous system.,1,1,1,1
Q21_A8,9,"In particular, recent studies have demonstrated an involvement of the immune response (both innate and adaptive) and the stimulation and secretion of mediators (cytokines and chemokines) that may be responsible for the painful symptoms, whereas glial cells such as satellite and Schwann cells might contribute to the maintenance of the neuroinflammatory process in DRG and axons respectively.",Recent studies have shown an immune response and the activation of anti-inflammatory mediators that may be responsible for painful symptoms of CIPN.,0,0,0,1
Q21_A8,10,"Moreover, neuroinflammatory components have also been shown in the spinal cord with microglia and astrocytes playing an important role in CIPN development.",Inflammatory markers have also been shown in the spinal cord with certain cells playing an important role in CIPN development.,1,1,1,1
Q21_A8,11,"Taking together, better understanding of these aspects would permit the development of possible strategies in order to improve the management of CIPN.",Better understanding of the causes of CIPN would allow for possible strategies to improve the management of CIPN.,1,1,1,1
Q22_A3,1,Chamomile is one of the most ancient medicinal herbs known to mankind.,Chamomile is one of the oldest herbs with medical effects known to mankind.,1,1,1,1
Q22_A3,2,It is a member of Asteraceae/Compositae family and represented by two common varieties viz.,Chamomile is part of the Asteraceae/Compositae family and is represented by two common types.,1,0,1,1
Q22_A3,3,German Chamomile (Chamomilla recutita) and Roman Chamomile (Chamaemelum nobile).,The two common types of chamomile are German Chamomile and Roman Chamomile.,1,1,1,1
Q22_A3,4,The dried flowers of chamomile contain many terpenoids and flavonoids contributing to its medicinal properties.,Dried chamomile flowers have medical features because they contain many natural substances like terpenoids and flavonoids.,1,1,1,1
Q22_A3,5,"Chamomile preparations are commonly used for many human ailments such as hay fever, inflammation, muscle spasms, menstrual disorders, insomnia, ulcers, wounds, gastrointestinal disorders, rheumatic pain, and hemorrhoids.","Chamomile is commonly used for many health problems in people like hay fever, swelling, muscle spasms, menstrual problems, sleeping problems, ulcers, wounds, stomach problems, rheumatoid pain, and hemorrhoids.",1,1,1,1
Q22_A3,6,Essential oils of chamomile are used extensively in cosmetics and aromatherapy.,Chamomile essential oils are used a lot in makeup and aromatherapy.,1,1,1,1
Q22_A3,7,"Many different preparations of chamomile have been developed, the most popular of which is in the form of herbal tea consumed more than one million cups per day.","Chamomile has been prepared many different ways. Over one million cups of chamomile herbal tea are drank per day, making it the most popular form of chamomile.",1,1,1,0
Q22_A3,8,"In this review we describe the use of chamomile in traditional medicine with regard to evaluating its curative and preventive properties, highlight recent findings for its development as a therapeutic agent promoting human health.",We looked at chamomile's use in medicine to understand and highlight it's healing and protecting features that improve people's health.,1,1,1,0
Q23_A9,1,"This study aims to introduce a resistance training protocol (6 repetitions × 70% of 1 maximum repetition (1RM), followed by 6 repetitions × 50% of 1RM within the same set) specifically designed for postmenopausal women with osteopenia/osteoporosis and monitor the effect of the protocol on bone mineral density (BMD) in the lumbar spine, assessed by dual-energy X-ray absorptiometry (DEXA).",This study introduces a resistance training protocol designed for postmenopausal women with weak or brittle bones. This study monitors the effect of the protocol on bone mineral density (BMD) in the lower spine. The protocol involves repetitions of physical activity at different intensity levels.,1.0,1.0,1.0,1.0
Q23_A9,2,"The subjects included in the study were 29 postmenopausal women (56.5 ± 2.8 years) with osteopenia or osteoporosis; they were separated into two groups: the experimental group (n = 15), in which the subjects participated in the strength training protocol for a period of 6 months; and the control group (n = 14), in which the subjects did not take part in any physical activity.",The study included 29 postmenopausal women with weak or brittle bones. They were separated into two groups: (1) subjects participated in the strength training protocol for 6 months or (2) subjects did not take part in any physical activity.,1.0,1.0,1.0,1.0
Q23_A9,3,BMD in the lumbar spine was measured by DEXA.,BMD in the lower spine was measured.,1.0,1.0,1.0,1.0
Q23_A9,4,The measurements were performed at the beginning and end of the study.,Measurements were performed at the beginning and end of the study.,1.0,1.0,1.0,1.0
Q23_A9,5,"A statistically significant increase (Δ% = 1.82%) in BMD was observed at the end of the study for the exercise group (0.778 ± 0.042 at baseline vs. 0.792 ± 0.046 after 6 months, p = 0.018, 95% CI [-0.025, -0.003]); while an increase was observed for the control group (Δ% = 0.14%), the difference was not statistically significant (0.762 ± 0.057 at baseline vs. 0.763 ± 0.059, p = 0.85, 95% CI [-0.013, 0.011]).",BMD was highly increased at the end of the study for the exercise group. A not-significant increase was seen for the no exercise group.,1.0,1.0,1.0,1.0
Q23_A9,6,"In conclusion, our strength training protocol seems to be effective in increasing BMD among women with osteopenia/osteoporosis and represents an affordable strategy for preventing future bone loss.","In conclusion, this strength training protocol was effective in increasing BMD among women with weak/brittle bones. This may be an affordable strategy to prevent future bone loss.",1.0,1.0,1.0,1.0
Q24_A1,1,"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly contagious virus that infects humans and a number of animal species causing coronavirus disease-19 (COVID-19), a respiratory distress syndrome which has provoked a global pandemic and a serious health crisis in most countries across our planet.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly contagious virus that infects humans and a number of animal species causing coronavirus disease-19 (COVID-19), a disease that attacks the respiratory system (parts of the body involved in breathing) which has led to a global pandemic (a large spread of disease) and a serious health crisis in most countries across our planet.",-1,0,1,1
Q24_A1,2,"COVID-19 inflammation is mediated by IL-1, a disease that can cause symptoms such as fever, cough, lung inflammation, thrombosis, stroke, renal failure and headache, to name a few.","Symptoms of COVID-19 are controlled by IL-1, a molecular body that can cause symptoms such as fever, cough, lung inflammation (irritation or swelling in the lungs), thrombosis (formation of blood clots inside blood vessels), stroke, kidney failure and headache, to name a few.",-1,1,1,1
Q24_A1,3,Strategies that inhibit IL-1 are certainly helpful in COVID-19 and can represent one of the therapeutic options.,Strategies that block IL-1 can help with COVID-19 and can represent an option for treatment.,1,1,1,1
Q24_A1,4,"However, until now, COVID-19 therapy has been scarce and, in many cases, ineffective, since there are no specific drugs other than the vaccine that can solve this serious health problem.","However, until now, treatment for COVID-19 has been limited and, in many cases, has not worked. This is because there are no specific drugs other than the vaccine that can solve this serious health problem.",1,1,1,1
Q24_A1,5,"Messenger RNA (mRNA) vaccines which are the newest approach, are already available and will certainly meet the many expectations that the population is waiting for.",Messenger RNA (genetic material that tells the body how to make certain proteins) (mRNA) vaccines are the newest approach to treatment that are already available and will certainly meet the many expectations that the population is waiting for.,-1,1,1,1
Q24_A1,6,"mRNA vaccines, coated with protected soft fatty lipids, use genetic mRNA (plus various inactive excipients) to make a piece of the coronavirus spike protein, which will instruct the immune system to produce specific antibodies.",mRNA vaccines use genetic mRNA to make a piece of the coronavirus spike protein (a crown-like structure on the surface of the virus that helps it enter the human cell). mRNA will then instruct the immune system to produce specific proteins called antibodies that counteract harmful substances.,1,1,0,1
Q24_A1,7,The soft fatty lipids allow the entry of mRNA into cells where it is absorbed into the cytoplasm and initiates the synthesis of the spike protein.,mRNA vaccines are coated with molecules called soft fatty lipids that allow mRNA to enter the cell where it is absorbed into the cytoplasm (the fluids inside a cell) and begin the creation of the spike protein.,-1,1,1,1
Q24_A1,8,"In addition, vaccination also activates T cells that help the immune system respond to further exposure to the coronavirus.","Additionally, vaccination also activates T cells (a type of white blood cell) that help the immune system respond to further exposure to the coronavirus.",1,1,1,1
Q24_A1,9,mRNA induces the synthesis of antigens of SARS-CoV-2 virus which stimulate the antibody response of the vaccinated person with the production of neutralizing antibodies.,mRNA prompts the creation of antigens (substances that signal an immune response) of SARS-CoV-2 virus which then signals the body of a vaccinated person to produce antibodies.,0,1,1,1
Q24_A1,10,"The new variant of the coronavirus-19 has been detected in the UK where, at the moment, the London government has imposed a lockdown with restrictions on international movements.","The new version, or variant, of SARS-CoV-2 has been detected in the UK. At the moment, the London government has started a lockdown with restrictions on movements outside the country.",1,1,1,1
Q24_A1,11,"The virus variant had already infected 1/4 of the total cases and in December 2020, it reached 2/3 of those infected in the UK.","The new variant had already infected 1/4 of all COVID-19 cases. In December 2020, it reached 2/3 of those infected in the UK.",1,1,1,1
Q24_A1,12,"It has been noted that the spreading rate of the British variant could be greater than 70% of cases compared to the normal SARS-CoV-2 virus, with an R index growth of 0.4.",It is believed that the spreading rate of the British variant could be greater than 70% of cases compared to the normal SARS-CoV-2 virus.,1,1,1,1
Q24_A1,13,"Recent studies suggest that coronavirus-19 variation occurs at the level N501Y of the spike protein and involves 23 separate mutations on the spike, 17 of which are linked to the virus proteins, thus giving specific characteristics to the virus.",Recent studies suggest that SARS-CoV-2 variation occurs due to a mutation called N501Y. N501Y affects the transmission (spreading) capabilities of the spike protein as well as several other mutations that give specific characteristics to the virus.,1,1,0,1
Q24_A1,14,"In general, coronaviruses undergo many mutations that are often not decisive for their biological behavior and does not significantly alter the structure and the components of the virus.","In general, coronaviruses undergo many mutations that often result in insignificant changes to their behavior, structure, and components.",1,1,1,1
Q24_A1,15,This phenomenon also occurs in SARS-CoV-2.,This observation is also seen in SARS-CoV-2.,1,1,1,1
Q24_A1,16,It is highly probable that the variants recently described in the UK will not hinder vaccine-induced immunity.,It is very likely that the variants recently described in the UK will not get in the way of immunity given by vaccines.,1,1,1,1
Q24_A1,17,"In fact, the variant will not break the vaccine although it may have some chance of making it a little less effective.","In fact, the variant will not interrupt the vaccine. However, it may have some chance of making it a little less effective.",1,1,0,1
Q24_A1,18,"Therefore, it is pertinent to think that the vaccine will work against the SARS-CoV-2 variant as well.","Therefore, the vaccine may work well against the SARS-CoV-2 variant as well.",1,1,1,1
Q24_A1,19,"In today's pandemic, the D614G mutation of the amino acid of corronavirus-19, which emerged in Europe in February 2020 is the most frequent form and causes high viral growth.","In today's pandemic, a mutation of the amino acids (the building blocks of proteins) in SARS-CoV-2 called D614G , which emerged in Europe in February 2020, is the most frequent form and causes high viral growth (an increased production of viruses).",-1,1,1,1
Q24_A1,20,The previously infrequent D614G mutation is now globally dominant.,The D614G mutation is now more common globally.,1,1,1,1
Q24_A1,21,"This variant, which is being tested by many international laboratories, is rapidly spreading across the countries and a series of vaccinated subjects are testing to see if their antibodies can neutralize the new variant of SARS-CoV-2.","This variant, which is being tested by many international laboratories, is rapidly spreading across the countries. There are a series of ongoing tests with vaccinated people to see if their antibodies can counteract the new variant of SARS-CoV-2.",1,1,1,1
Q24_A1,22,This variant has a very high viral growth and is less detectable with the RT-PCR technique in the laboratory.,"This variant has a very high viral growth and is less detectable with the RT-PCR technique in the laboratory, which is a method to detect the presence of SARS-CoV-2.",1,0,1,0
Q24_A1,23,"It has been reported that the British variant that increases viral load does not cause more severe effects in the respiratory tract and lung disease, therefore, it is certain that the variant is growing rapidly and must be kept under control; for this reason, laboratory data is expected impatiently.","It has been reported that the British variant that increases viral load (the amount of virus) does not cause more severe effects in the respiratory system and lung disease. Therefore, it is likely that the variant is growing rapidly and must be kept under control. For this reason, there is a high demand for laboratory data.",1,1,1,1
Q24_A1,24,The study on the many variants that coronavirus-19 presents is very interesting and complete and clearer data on this topic will be ready in the near future.,The study on the many variants that SARS-CoV-2 presents is very interesting. Complete and clearer data on this topic will be ready in the near future.,1,1,1,1
Q24_A1,25,"In addition, it is still unclear whether the different variants discovered in many countries, including Africa, share the same spike protein mutation and therefore, this is another study to elaborate on.","In addition, it is still unclear whether the different variants discovered in many countries, including Africa, share the same spike protein mutation. Another study is needed to investigate this.",0,1,1,1
Q24_A1,26,"In order to be certain and to not have unexpected surprises, we need to reduce the spread and the transmission speed of viral variants that could appear around the world, creating new pandemics.","In order to be certain and to not have unexpected surprises, we need to reduce the spread and the transmission speed of viral variants that could appear around the world, creating new pandemics.",-1,1,1,1
Q24_A1,27,"For this reason, the scientific community is on the alert since laboratory tests on serum antibodies from COVID-19 survivors have been reported to be less effective in attacking the variant.","For this reason, the scientific community is on the alert since laboratory tests on serum antibodies from COVID-19 survivors (in other words, antibodies not prompted by vaccines) have been reported to be less effective in attacking the variant.",0,1,1,1
Q24_A1,28,"In light of the above, the scientific community must be on the alert as larger variants of the spike protein could escape vaccine-induced antibodies, which for now are of great help to the community and can save millions of lives.","In light of what we know so far, the scientific community must be on alert as larger variants of the spike protein could avoid antibodies prompted by vaccines, which for now are very helpful and can save millions of lives.",-1,1,1,1
Q24_A1,29,Deepening the study of spike protein mutations will help to better understand how to combat coronavirus-19 and its variants.,More research on spike protein mutations will help to better understand how to combat coronavirus-19 and its variants.,1,1,1,1
Q25_A1,1,"Experimental, epidemiologic and clinical studies have provided strong evidence that physical exercise has beneficial effects on multiple physiological variables affecting cardiovascular health (lipoprotein levels, rest blood pressure and heart rate, carbohydrate tolerance, neurohormonal activity).","Studies have provided strong evidence that exercise has beneficial effects on multiple internal biological variables that affect heart health. These biological variables include: lipoprotein levels, resting blood pressure and heart rate, carbohydrate tolerance, and neurohormonal activity.",0,0,1,1
Q25_A1,2,Regular exercise has been shown to slow the progression of cardiovascular disease and to reduce cardiovascular morbidity and mortality.,Regular exercise has been shown to slow the progression of heart disease and to reduce the risk of heart disease and death.,1,1,1,1
Q25_A1,3,"More recently, exercise-induced increases in blood flow and shear stress have been observed to enhance vascular function and structure.","Recently, increased blood flow due to exercise or stress has been observed to enhance the function and structure of blood vessels.",1,1,1,1
Q25_A1,4,"By increasing the release of nitric oxide and prostacyclin, shear stress augments endothelium-dependent vasodilation and inhibits multiple processes involved in atherogenesis and restenosis.","Stress increases the release of vasodilators that increase blood flow (e.g. nitric oxide and prostacyclin). These vasodilators increase vasodilation, or the widening of blood vessels, and inhibits processes associated with heart disease and death.",0,0,1,1
Q25_A1,5,In this review we discuss the underlying mechanisms by which exercise-induced blood flow and shear stress exert their salutary effects on cardiovascular remodeling.,"In this review, the authors discuss the underlying mechanisms that explain how increased blood flow due to exercise and stress exert their beneficial effects on cardiovascular (i.e. heart and blood vessels) organ structure.",1,1,1,1
Q26_A2,1,Research on relationships between personality and cognitive abilities has so far resulted in inconsistent findings regarding the strength of the associations.,Research on relationships between personality and cognitive abilities has produced inconsistent findings regarding how strongly the two points are correlated.,0.0,0.0,1.0,1.0
Q26_A2,2,"Moreover, relationships have rarely been compared longitudinally and bidirectionally between midlife versus late-life cohorts by considering different personality traits as well as multiple cognitive domains over a long-term follow-up period.",Relationships have rarely been compared between midlife versus late-life cohorts by considering different personality traits as well as multiple cognitive domains over a long-term follow-up period.,0.0,0.0,1.0,1.0
Q26_A2,3,"We hypothesize that the interplay between the ""Big Five"" personality traits (Neuroticism, Extraversion, Openness to Experience, Agreeableness and Conscientiousness) and cognitive abilities (information processing speed, crystallized intelligence, fluid intelligence) may change from midlife to old age due to age-associated changes in cognitive and personality plasticity.","The study hypothesized that the relationship between the ""Big Five"" personality traits and cognitive abilities (information processing speed, crystallized intelligence, fluid intelligence) may change from midlife to old age. This may be due to age-associated changes in cognitive and personality plasticity. The ""Big Five"" personality traits include: Neuroticism, Extraversion, Openness to Experience, Agreeableness, and Conscientiousness.",1.0,0.0,1.0,1.0
Q26_A2,4,"We used data from the German Interdisciplinary Longitudinal Study of Adult Development (ILSE study; n = 1,002).",We used data from the German Interdisciplinary Longitudinal Study of Adult Development.,1.0,1.0,1.0,1.0
Q26_A2,5,"Participants were either born in 1950/52 (midlife sample, n = 502) or in 1930/32 (late-life sample, n = 500) and followed up for up to 12 years.",Participants were either born in 1950/52 or in 1930/32 and followed up for up to 12 years.,1.0,1.0,1.0,1.0
Q26_A2,6,"Based on bivariate latent change score regression models (adjusted for gender, education, self-rated and physician-rated health), we observed that, apart from very few exceptions, the intervariable cross-lagged associations between personality traits and cognitive abilities were generally similar between cohorts.","The study noted that, apart from very few exceptions, the association between personality traits and cognitive abilities were similar between cohorts.",1.0,0.0,1.0,1.0
Q26_A2,7,"Moreover, in case of neuroticism, extraversion, and openness, the effects of cognitive abilities on change in personality were stronger than the reversed effects.","In cases of extreme positive or negative emotions, the effects of cognitive abilities on personality change were stronger than the reversed effects.",1.0,0.0,0.0,1.0
Q26_A2,8,"Our findings thus suggest that the so far predominant perspective of personality in middle adulthood and late-life as a predictor, rather than as an outcome, of cognitive abilities needs more differentiation and reconsideration.","Findings suggest that more research is needed to determine if personality in middle adulthood and late-life is a predictor, rather than as an outcome, of cognitive abilities.",1.0,1.0,1.0,1.0
Q27_A1,1,Background: Carpal tunnel syndrome is a common cause of neurological symptomatology.,Carpal tunnel syndrome is a common cause of health effects within the nervous system.,1.0,1.0,1.0,1.0
Q27_A1,2,Surgical decompression remains the treatment of choice in patients not responding to conservative therapies.,"Surgical decompression, a surgery that compresses nerves, remains the treatment of choice in patients not responding other options.",1.0,1.0,-1.0,0.0
Q27_A1,3,The aim of this study was to assess the effectiveness of standard open decompression by analysis of symptomatic and functional improvement and to assess whether a general surgeon can still perform this operation safely.,The goal of this study was to assess the effectiveness of standard open decompression. This was done by analyzing symptoms and functional improvement or movement ability. This study also aimed to assess whether a general surgeon can still perform this operation safely.,0.0,1.0,1.0,1.0
Q27_A1,4,Patients and methods: Patients undergoing standard open carpal tunnel release by a single general surgeon were recruited.,"Patients undergoing standard open carpal tunnel release, a surgery to treat carpal tunnel, by a general surgeon were recruited.",1.0,1.0,1.0,0.0
Q27_A1,5,A self-administered Boston questionnaire was used to assess symptom severity and functional status pre- and post-surgical intervention.,A questionnaire was used to assess symptoms and functional status pre- and post-surgery.,0.0,1.0,1.0,1.0
Q27_A1,6,Results: Forty-seven patients (51 hands) underwent carpal tunnel release and 32 patients completed the questionnaire.,Forty-seven patients (51 hands) underwent carpal tunnel release and 32 patients completed the questionnaire.,0.0,1.0,1.0,1.0
Q27_A1,7,"88% had a significant reduction in the symptom severity score, while improvement in function status score was achieved in 79% of patients.",The majority of patients had a significant reduction in the severity of their symptoms. The majority of patients had improvement in their function status.,1.0,1.0,1.0,1.0
Q27_A1,8,"Mean symptom severity score improved from 3.41 points preoperatively to 1.85 (p < 0.0001) points at the last follow up examination, while the mean function status score improved from 2.73 to 1.99 points (p < 0.0001).",Symptom severity and functional movement scores were improved at the last follow up examination.,1.0,1.0,1.0,1.0
Q27_A1,9,Outcome was poor in six patients with slight worsening of either symptom or function status score.,Health effects were poor in six patients with slight worsening of either symptom or function status.,1.0,1.0,1.0,1.0
Q27_A1,10,Three patients were treated conservatively for minor wound infection without long-term sequelae.,Three patients were treated conservatively for minor wound infection without long-term health effects.,1.0,1.0,1.0,1.0
Q27_A1,11,Discussion: Standard open carpal tunnel release still provides efficacious symptomatic relief with a low risk of associated complications when performed by a general surgeon.,Standard open carpal tunnel release still provides effective symptom relief with a low risk of surgical complications when performed by a general surgeon.,1.0,1.0,1.0,1.0
Q28_A2,1,"A fifty-year-old woman was admitted to our hospital because of generalized edema, progressive symptoms of fatigue and weakness of ten years' duration.",A fifty-year-old woman was admitted to the hospital because of swelling throughout the body along with increasing tiredness and weakness of over ten years.,1.0,1.0,1.0,1.0
Q28_A2,2,"After an uneventful third delivery, 24 years before admission, she could not lactate and developed oligomenorrhea and then amenorrhea.","After a normal third childbirth experience, 24 years before hospital admission, she could not lactate. The patient developed oligomenorrhea, infrequent menstrual periods, and then amenorrhea, the lack of menstruation.",1.0,1.0,1.0,1.0
Q28_A2,3,Laboratory evaluation revealed panhypopituitarism and pituitary cell antibodies were positive.,"Exams revealed panhypopituitarism, a condition marked by decreased pituitary hormone production and release. Exams also found pituitary cell antibodies which are markers of autoimmunity against pituitary glands.",1.0,0.0,1.0,1.0
Q28_A2,4,Both CT scans and MR images showed empty sella.,"Brain scans showed an empty sella, or a bony cavity at the base of the brain that protects that pituitary gland.",1.0,1.0,1.0,1.0
Q28_A2,5,This case is postpartum hypopituitarism without a preceding history of excessive bleeding and may be autoimmune hypophysitis.,"This case represents hypopituitarism after childbirth, without a history of excessive bleeding. This case may be autoimmune hypophysitis or inflammation of the pituitary gland.",1.0,0.0,1.0,1.0
Q29_A1,1,Renal artery stenosis (RAS) is the most common correctable cause of hypertension.,Renal artery stenosis (RAS) is when one or more of the arteries that carry blood to your kidneys is narrowed. RAS is the most common correctable cause of hypertension or high blood pressure,1,1,1,1
Q29_A1,2,The current study was undertaken to evaluate the usefulness of color Doppler flow imaging as a screening examination in the detection of significant RAS.,The goal of the study was to evaluate the usefulness of color Doppler flow imaging as a screening test to detect RAS.,0,0,1,1
Q29_A1,3,Fifty-five kidneys in 30 patients were examined with aortography and color Doppler flow imaging in a double-blind fashion.,Fifty-five kidneys in 30 patients were examined with aortography (use of injected dye to image within the body) and color Doppler flow imaging.,1,1,1,1
Q29_A1,4,"The peak systolic velocity (PSV) in the renal artery, the renal-aortic ratio (RAR) (ie, the ratio of the PSV in the renal artery to the PSV in the aorta), and the renal artery resistive index were determined and compared with the percentage of stenosis as determined with angiography.","Several data points were collected, including: peak systolic velocity (PSV) in the renal artery, the renal-aortic ratio (RAR) (i.e., the ratio of the PSV in the renal artery to the PSV in the aorta), and the renal artery resistive index. These points were then compared with the percentage of blood vessel narrowing identified by angiography.",1,0,1,1
Q29_A1,5,Ultrasound (US) criteria used to diagnose RAS were (a) an RAR of 3.5 or greater and/or (b) a renal artery PSV of greater than 100 cm/sec.,Criteria used to diagnose RAS were (a) an RAR of 3.5 or greater and/or (b) a renal artery PSV of greater than 100 cm/sec.,1,1,1,1
Q29_A1,6,Doppler tracings were obtained in 25 (69%) of 36 kidneys with a patent single renal artery.,Doppler tracings were obtained in 25 of 36 kidneys that had only one renal artery open.,1,1,1,1
Q29_A1,7,RAR and PSV each yielded a sensitivity of 0% in the diagnosis of RAS.,RAR and PSV each yielded a sensitivity of 0% in the diagnosis of RAS.,0,0,1,1
Q29_A1,8,Doppler tracings were obtained in three (50%) of six occluded renal arteries.,Doppler tracings were gotten in three of six closed renal arteries.,1,1,1,1
Q29_A1,9,"Accessory arteries were present in 13 (24%) of 55 kidneys, but none were visualized with color Doppler flow imaging.","Accessory arteries were present in 13 of 55 kidneys, but none were visualized with color Doppler flow imaging.",0,0,1,1
Q29_A1,10,"The authors conclude that with current technical capability, color duplex US is not an adequate screening method for the detection of RAS.",The authors conclude that color duplex US is not an good screening method for RAS detection.,0,1,1,1
Q30_A3,1,"The acute onset of purple digits is a concerning manifestation and may represent underlying, potentially life-threatening disease.","The sudden occurrence of purple fingers is serious and may be due to underlying, possibly life-threatening disease.",1.0,1.0,1.0,1.0
Q30_A3,2,"Correctly identifying the etiology of purple digits is essential to proper management, and can aid in the diagnosis of systemic disease.",Finding the correct cause of purple fingers is important for treatment and can help diagnose diseases that affect the entire body.,1.0,1.0,1.0,1.0
Q30_A3,3,Multiple causes of purple digits and significant overlap in clinical presentation can make diagnosis difficult.,Many causes of purple fingers and similar symptoms can make it hard to diagnose.,1.0,1.0,1.0,1.0
Q30_A3,4,"Despite the various causes of acute purple digits in the published literature, an algorithmic approach to the evaluation and management of the most common and alarming etiologies has yet to be established.","Even though studies show purple fingers have many causes, a predetermined set of rules to help doctors diagnose and treat the most common and worrisome causes does not exist.",0.0,1.0,1.0,1.0
Q30_A3,5,The initial step in evaluating a patient with purple digits is to determine if the cause is associated with hypoxemia or trauma.,The first step in treating a patient with purple fingers is to figure out if the cause is due to a low level of oxygen in the blood or injury.,1.0,1.0,1.0,1.0
Q30_A3,6,"If the patient is in a stable condition, the dermatologist needs to determine if the process could be related to cold exposure such as Raynaud phenomenon, acrocyanosis, pernio, cryoglobulinemia or frostbite.","If the patient is in reasonable health, the dermatologist needs to see if purple fingers could be from cold exposure.",1.0,1.0,1.0,1.0
Q30_A3,7,"If the disease occurs independent of temperature, physical examination and histological evaluation of the skin is recommended.","If the disease happens regardless of temperature, doctors should do an exam and look at the skin under a microscope.",1.0,1.0,1.0,1.0
Q30_A3,8,The lack of peripheral pulses are concerning for acute arterial thrombosis from peripheral vascular disease or arterial embolism.,No pulse in the hands or legs could mean a blood clot in an artery.,1.0,1.0,1.0,1.0
Q30_A3,9,"Non-blanching skin changes on the digit that lack inflammation and microthrombosis most likely represent a bleeding or platelet abnormality; however, if microthrombi are identified a more life-threatening processes such as purpura fulminans or embolic phenomenon may be occurring.","Finger skin changes that do not turn white when pressed, are not red and sore, and do not have small blood clots are likely caused by a blood problem. A life-threatening situation may be happening if there are small blood clots.",1.0,1.0,1.0,1.0
Q30_A3,10,Evidence of blood vessel inflammation suggests a leukocytoclastic vasculitis.,The body's immune system attacking the blood vessel by mistake could mean small blood vessel inflammation.,1.0,1.0,1.0,1.0
Q30_A3,11,The patient with a purple blanching digit and normal pulses requires an extensive historical review to help determine the cause.,Doctors should ask a patient with a purple finger that turns white when pressed a series of questions to determine the cause.,1.0,1.0,1.0,1.0
Q30_A3,12,This review presents an algorithmic approach to assist in the evaluation and management of the purple digit.,We describe a predetermined set of rules to help doctors diagnose and treat a purple finger.,1.0,1.0,1.0,1.0
Q31_A10,1,"Background: Chronic health conditions and polypharmacy are common among the older population and associated with increased risks of adverse events, medicine-interactions, geriatric syndromes, falls and mortality.","Chronic health conditions and polypharmacy, or the simultaneous use of medications to treat a single condition, are common among older adults and associated with increased risks of adverse events, medicine-interactions, geriatric syndromes, falls and death.",-1,0,0,1
Q31_A10,2,Poor nutrition is also common in older people.,Poor nutrition is also common in older people.,1,1,1,1
Q31_A10,3,Causal associations between medication use and older people's nutrient status is seldom discussed.,The impact between medication use and older people's nutrient status is rarely talked about.,1,1,1,0
Q31_A10,4,"Objectives: The objectives of this review were to summarise the literature reporting associations between medicines commonly prescribed to older adults and nutrient deficiencies, and to discuss the clinical implications and management.","We summarized the literature reporting relationships between medicines commonly prescribed to older adults and nutrient deficiencies, and discussed the clinical impacts and management.",0,1,1,1
Q31_A10,5,Methods: Medicine information resources (n = 5) were searched for information about nutrient deficiencies associated with common medicines used by older people and listed within the top 50 medicines prescribed by volume on the Australian Pharmaceutical Benefits Scheme.,Five medicine information resources were searched for information about nutrient deficiencies related to common medicines used by older people and listed within the top 50 medicines prescribed by volume on the Australian Pharmaceutical Benefits Scheme.,-1,1,1,1
Q31_A10,7,"Data was extracted, tabulated and summarised with clinical information relevant to pharmacists and clinicians involved in the care of older people taking medicines.","Data was removed, tabulated and summarized with clinical information related to pharmacists and clinicians involved in the care of older people taking medicines.",0,1,1,1
Q31_A10,8,Results: A total of 23 clinical studies were identified reporting medicine-induced nutrient deficiencies in older adults.,We found a total of 23 clinical studies reporting medicine-caused nutrient deficiencies in older adults.,1,1,1,1
Q31_A10,9,"Vitamin B12, sodium, magnesium were identified as the 3 main nutrients susceptible to deficiency by medicines used to treat cardiovascular disease, neurological conditions, gastrointestinal conditions, and diabetes.","Vitamin B12, sodium, and magnesium were identified as the 3 main nutrients at risk for deficiency by medicines used to treat heart disease, nerve conditions, conditions of the gut, and diabetes.",0,1,1,1
Q31_A10,10,The coenzyme CoQ10 was depleted by statins.,"A coenzyme (CoQ10) was diminished by statins, or cholesterol-lowering medicines.",1,0,1,1
Q31_A10,11,Conclusion: Certain medicines commonly prescribed to older adults are associated with nutrient deficiencies that may be clinically significant.,We found that certain medicines commonly prescribed to older adults are related to nutrient deficiencies that may be clinically important.,1,1,1,1
Q31_A10,12,"Given the high prevalence of comorbidities and polypharmacy it is possible that some of these individual drug-induced nutrient deficiencies are compounded, warranting both clinical and research attention.","Given the high prevalence, or a condition of being widespread in a particular area or at a particular time, of comorbidities and polypharmacy it is possible that some of these individual drug-induced nutrient deficiencies are compounded, warranting both clinical and research attention.",-1,0,1,1
Q32_A2,1,"Objectives: Interictal epileptiform discharges (IEDs) have been linked to memory impairment, but the spatial and temporal dynamics of this relationship remain elusive.","Interictal epileptiform discharges (IEDs) are spikes or waves detected within the brain without a seizure occurring. IEDs  have been linked to memory impairment. However, it is not understood what role spatial (space) and temporal (time) dynamics play.",1,1,1,1
Q32_A2,2,"In the present study, we aim to systematically characterize the brain areas and times at which IEDs affect memory.",The present study aimed to characterize the brain areas and times at which IEDs affect memory.,1,1,1,1
Q32_A2,3,Methods: Eighty epilepsy patients participated in a delayed free recall task while undergoing intracranial electroencephalography (EEG) monitoring.,"Eighty epilepsy patients participated in a delayed free recall task. All patients completed the task under intracranial electroencephalography (EEG) monitoring, or a test where electrical activity of the brain is recorded.",1,1,1,1
Q32_A2,4,We analyzed the locations and timing of IEDs relative to the behavioral data in order to measure their effects on memory.,The study analyzed the locations and timing of IEDs relative to behavioral data to measure their effects on memory.,1,1,1,1
Q32_A2,5,"Results: Overall IED rates did not correlate with task performance across subjects (r = 0.03, p = 0.8).",Overall the amount of IEDs did not impact task performance across subjects.,1,1,1,1
Q32_A2,6,"However, at a finer temporal scale, within-subject memory was negatively affected by IEDs during the encoding and recall periods of the task but not during the rest and distractor periods (p < 0.01, p < 0.001, p = 0.3, and p = 0.8, respectively).","However, within-subject memory was negatively affected by IEDs during the encoding (learning) and recall periods of the task. This effect was not seen when patients rested or were distracted.",1,0,0,1
Q32_A2,7,The effects of IEDs during encoding and recall were stronger in the left hemisphere than in the right (p < 0.05).,The effects of IEDs during encoding  and recall were stronger in the left hemisphere than in the right.,1,0,1,1
Q32_A2,8,"Of six brain areas analyzed, IEDs in the inferior-temporal, medial-temporal, and parietal areas significantly affected memory (false discovery rate < 0.05).","Six brain areas were analyzed. IEDs in the inferior-temporal, medial-temporal, and parietal areas significantly affected memory.",1,0,1,1
Q32_A2,9,Significance: These findings reveal a network of brain areas sensitive to IEDs with key nodes in temporal as well as parietal lobes.,These findings show a network of brain areas sensitive to IEDs with key areas in the temporal and parietal lobes.,1,0,1,1
Q32_A2,10,They also demonstrate the time-dependent effects of IEDs in this network on memory.,These findings also show the time-dependent effects of IEDs  on memory.,1,1,1,1
Q33_A9,1,"Rationale: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes long-term pulmonary sequelae in adults, but little is known about pulmonary outcomes in pediatrics.",COVID-19 leads to long-term lung complications in adults. We don't know if youth experience the same complications.,1.0,1.0,1.0,1.0
Q33_A9,2,Objective(s): The aim of this study was to describe long-term subjective and objective pulmonary abnormalities after SARS-CoV-2 infection in pediatric populations.,The goal of this study was to find out what lung complications are experienced by youth after they get COVID-19.,1.0,1.0,1.0,1.0
Q33_A9,3,"Methods: Single-center, retrospective cohort of patients seen in post-coronavirus disease 2019 (COVID-19) pulmonary clinic in 2021.",We looked through records of youth patients who went to a health clinic for COVID-19 in 2021.,1.0,1.0,1.0,1.0
Q33_A9,4,Subjects evaluated had persistent pulmonary symptoms 4 weeks or more after initial infection.,Patients reported constant lung problems 4 or more weeks after getting infected with COVID-19.,1.0,1.0,1.0,1.0
Q33_A9,5,"Clinical testing included a 6-min walk test (6MWT), chest X-ray, pre- and postbronchodilator spirometry, plethysmography, and diffusion capacity.",We looked through patients' results from various lung function tests.,1.0,1.0,1.0,1.0
Q33_A9,6,Patients were followed 2-to-3-months after the initial visit with repeat testing.,Patients were first followed 2-to-3-months after the first visit and then were tested again periodically.,1.0,1.0,1.0,1.0
Q33_A9,7,The primary outcome was the presence of abnormal pulmonary function testing.,We were primarily interested in finding unusual results from lung function testing.,1.0,1.0,1.0,1.0
Q33_A9,8,Secondary measures included variables associated with pulmonary outcomes.,We also looked for factors that might affect lung function results.,1.0,1.0,1.0,1.0
Q33_A9,9,"Results: Eighty-two adolescents were seen at a median of 3.5 months postinfection, with approximately 80% reporting two or more symptoms at clinic presentation (cough, chest pain, dyspnea at rest, and exertional dyspnea).","We included 82 youth in this study. Results showed that patients went to a health clinic, on average, 3.5 months after getting infected with COVID-19. 80% of them reported two or more symptoms such as coughing, chest pain, and difficulty breathing when either at rest or during exercise.",1.0,1.0,1.0,1.0
Q33_A9,10,At follow-up (~6.5 months) exertional dyspnea persisted for most (67%).,"During the 6.5 month follow-up, 65% of patients experienced difficulty breathing during exercise.",1.0,1.0,1.0,1.0
Q33_A9,11,"Spirometry was normal in 77% of patients, but 31% had a positive bronchodilator response.","Spirometry (a breathing test) results were normal in 77% of patients, but 31% had results that suggest poor lung function from the bronchodilator response test (another kind of breathing test).",1.0,1.0,1.0,1.0
Q33_A9,12,No abnormalities were noted on plethysmography or diffusion capacity.,All other results from lung function tests were normal.,1.0,1.0,1.0,1.0
Q33_A9,13,"Clinical phenotypes identified included inhaled corticosteroid responsiveness, paradoxical vocal fold motion disorder, deconditioning, and dysautonomia.","Other clinical patient observations that were noted included improved lung function after taking steroids, unusual movement of the vocal cords when breathing, loss in body function, and dysautonomia (malfunctioning of nerves that perform involuntary body functions).",0.0,1.0,1.0,1.0
Q33_A9,14,"Multivariable modeling demonstrated that obesity, anxiety, and resting dyspnea were associated with reduced 6MWT, while female sex and resting dyspnea were associated with higher Borg Dyspnea and Fatigues scores.","Results also showed that obesity, anxiety, and difficulty breathing at rest negatively affected patients' performance in the 6-minute walk test (how far you can walk in six minutes). Scoring high on tests that rate your difficulty in breathing and severity of fatigue (or tiredness) was more likely for patients who were female and had difficulty breathing at rest.",1.0,1.0,1.0,1.0
Q33_A9,15,Conclusions: This is the largest study to date of pediatric patients with long-term pulmonary sequelae post-COVID-19.,"In summary, this is the largest study to date that looked at long-term complications from COVID-19 in youth patients.",1.0,1.0,1.0,1.0
Q33_A9,16,Identified clinical phenotypes and risk factors warrant further study and treatment.,Future research is needed to better under understand the other clinical observations and factors that increase risk of lung problems.,0.0,1.0,1.0,1.0
Q34_A5,1,Functional neurologic disorder (FND)/conversion disorder is a prevalent and disabling condition at the intersection of neurology and psychiatry.,"Functional neurological disorder (FND) is a condition involving issues in the functioning of the nervous system and brain, also known as conversion disorder. It is a widespread and disabling condition where neurology (the branch of medicine focused on the brain and nervous system) and psychiatry (the branch of medicine focused on mental illnesses) overlap.",0,1,1,1
Q34_A5,2,"Clinicians often report feeling ill-equipped treating patients with FND, perpetuated by a historically limited understanding of neurobiologic disease mechanisms.",Doctors often feel inadequate to treat patients with FND which is likely due to our limited understanding of how diseases in the brain and nervous system work.,-1,1,1,1
Q34_A5,3,"In this review, we summarize the neuroimaging literature across the spectrum of sensorimotor FND, including functional imaging studies during rest, sensorimotor performance, and emotional-processing tasks as well as structural magnetic resonance imaging findings.","In this summary of research, we talk about studies that focus on neuroimaging (the process that creates images of the brain or parts of the nervous system) as it relates to FND. Topics covered in these studies include neuroimaging that shows brain function when the body is at rest, sensorimotor performance (the process of receiving sensory messages and producing a physical response), and emotional processing tasks. Studies also talked about findings from structural magnetic imaging, which is a type of neuroimaging technique.",0,1,1,1
Q34_A5,4,"Particular attention is given to studies implicating the anterior and middle cingulate cortex and related salience network structures (insula, amygdala, and periaqueductal gray) in the neurobiology of FND.","We prioritized studies that suggested the potential roles played by the cingulate cortex (the part of the brain that helps process emotions and regulate behavior) and other related brain structures (such as the insula, amygdala, and peraqueductal gray) in the neurobiology (the mechanisms related to the nervous system) of FND.",-1,1,1,1
Q34_A5,5,"Neuroimaging studies identify cingulo-insular functional alterations during rest, motor performance, and emotion processing in FND populations.","The studies on neuroimaging found changes in a specific central region of the brain during rest, motor performance, and emotion processing in FND populations.",1,1,1,1
Q34_A5,6,"The literature also supports that patients with FND exhibit heightened amygdalar and periaqueductal gray reactivity to emotionally valenced stimuli, enhanced coupling between amygdalar and motor control areas, and increased amygdalar volumes.",The studies also highlighted that patients with FND showed the following symptoms: (1) increased reactivity in the brain (specifically the amygdala and periaqueductal gray) to emotional stimuli; (2) joint coordination between amygdalar (related to the amygdala) and motor control areas; and (3) increased size of the amygdala.,0,0,1,1
Q34_A5,7,"The structural neuroimaging literature also implicates cingulo-insular areas in the pathophysiology of FND, though these findings require replication and clarification.","The studies also suggest that changes in a specific central region of the brain can partly explain the unusual functional changes in the body that result from FND. However, more research is needed.",1,1,1,1
Q34_A5,8,"While more research is needed to fully elucidate the pathophysiology of FND, salience network alterations appear present in some FND populations and can be contextualized using biopsychosocial models for FND.","While more research is needed to fully understand the unusual functional changes in the body that result from FND, individuals with FND showed changes in the functioning of the brain structures involved in the process of emotions. These findings can be further investigated by applying biopsychosocial (biological, psychological and social factors) models for FND.",0,1,1,1
Q35_A8,1,Background: It is critical to developing an accurate method for differentiating between malignant and benign solitary pulmonary nodules.,It is important to create an accurate way for understanding which lung growths are cancerous and which are not.,1,1,1,1
Q35_A8,2,This study aimed was to establish a predicting model of lung nodules malignancy in a real-world setting.,The goal of this study was to create a model that predicts whether lung growths are cancerous in a real-world setting.,1,1,1,1
Q35_A8,3,"Methods: The authors retrospectively analysed the clinical and computed tomography (CT) data of 121 patients with lung nodules, submitted to percutaneous CT-guided transthoracic biopsy, between 2014 and 2015.",The authors looked at clinical data and x-rays of 121 patients with lung growths between 2014 and 2015.,1,1,1,1
Q35_A8,4,Multiple logistic regression was used to screen independent predictors for malignancy and to establish a clinical prediction model to evaluate the probability of malignancy.,Statistical models were used to create a prediction model that measures the probability of cancer.,1,1,1,1
Q35_A8,5,"Results: From a total of 121 patients, 75 (62%) were men and with a mean age of 64.7 years old.",75 (62%) of patient were men and had an average age of 65.7 years old.,1,1,1,0
Q35_A8,6,"Multivariate logistic regression analysis identified six independent predictors of malignancy: age, gender, smoking status, current extra-pulmonary cancer, air bronchogram and nodule size (p<0.05).","Statistical analysis found six risk factors for cancerous lung growths: age, gender, smoking status, current non-lung cancer, airways appearing distinct in x-rays, and lung growth size.",1,1,1,1
Q35_A8,8,"Conclusions: The prediction model established in this study can be used to assess the probability of malignancy in the Portuguese population, thereby providing help for the diagnosis of lung nodules and the selection of follow-up interventions.","The prediction model created in this study can be used to measure the probability of cancer in the Portuguese population, which helps with the diagnosis of lung growths and choosing follow-up management.",0,1,1,1
Q36_A4,1,"Purpose: As obesity rates continue to climb, the notion that overconsumption reflects an underlying 'food addiction' (FA) has become increasingly influential.","As obesity rates get higher, the idea that overeating is caused by an underlying 'food addiction' (FA) has gained popularity.",1.0,1.0,1.0,1.0
Q36_A4,2,"An increasingly popular theory is that sugar acts as an addictive agent, eliciting neurobiological changes similar to those seen in drug addiction.","Scientists increasingly believe sugar is addictive, causing similar changes in the brain as drug addiction.",1.0,1.0,1.0,1.0
Q36_A4,3,"In this paper, we review the evidence in support of sugar addiction.","In this paper, we review studies that show sugar addiction.",1.0,1.0,1.0,1.0
Q36_A4,4,"Methods: We reviewed the literature on food and sugar addiction and considered the evidence suggesting the addictiveness of highly processed foods, particularly those with high sugar content.","We reviewed studies on food and sugar addiction to determine the addictiveness of highly processed foods, especially those containing a lot of sugar.",0.0,1.0,1.0,1.0
Q36_A4,5,We then examined the addictive potential of sugar by contrasting evidence from the animal and human neuroscience literature on drug and sugar addiction.,We then looked at how addictive sugar might be by comparing brain studies on drug and sugar addiction in animals and humans.,1.0,1.0,1.0,1.0
Q36_A4,6,"Results: We find little evidence to support sugar addiction in humans, and findings from the animal literature suggest that addiction-like behaviours, such as bingeing, occur only in the context of intermittent access to sugar.","We did not find many studies showing sugar addiction in humans, and animal studies showed addiction-like behaviors, such as bingeing, happen only when sugar is given and taken away.",0.0,1.0,1.0,1.0
Q36_A4,7,"These behaviours likely arise from intermittent access to sweet tasting or highly palatable foods, not the neurochemical effects of sugar.","Occasional access to sweet tasting or tasty foods, not the brain chemistry effects of sugar, likely cause these behaviors.",1.0,1.0,1.0,1.0
Q36_A4,8,"Conclusion: Given the lack of evidence supporting it, we argue against a premature incorporation of sugar addiction into the scientific literature and public policy recommendations.",We conclude that sugar addiction should not be part of the state of the science and public policy recommendations due to a lack of information.,1.0,1.0,1.0,1.0
Q37_A2,1,"When used appropriately, immunization can effectively prevent many infections and diseases.","When used appropriately, the process in which a person becomes protected against a disease through vaccination (immunization) can effectively prevent many infections and diseases.",-1.0,0.0,1.0,1.0
Q37_A2,2,"Some vaccines, such as that for polio, are believed to produce lifelong immunity.","Some vaccines, such as those for polio, are thought to create lifelong immunity.",1.0,1.0,1.0,1.0
Q37_A2,3,"Others, such as those for tetanus and diphtheria, may require that a booster injection be given upon exposure to assure full immunity.","Other vaccines, such as those for tetanus and diphtheria, may require that a booster injection be given once exposed to assure full immunity.",1.0,1.0,1.0,1.0
Q37_A2,4,"Still others, such as that for influenza, confer immunity for only a limited time.","Still other vaccines, such as those for influenza, grant immunity for only a limited time.",1.0,1.0,1.0,1.0
Q37_A2,5,"Inoculation is not without risk, particularly in immunosuppressed, allergic, febrile, or pregnant patients.","Vaccination is not without risk, particularly in those who have weakened immune systems, allergies, fevers, or who are pregnant.",1.0,1.0,1.0,1.0
Q37_A2,6,"However, in otherwise healthy patients, serious sequelae are so rare that they are far overshadowed by the enormous benefits of immunization.","In otherwise healthy patients, serious undesired health outcomes from vaccination are so rare that they are overshadowed by the huge benefits of immunization.",1.0,1.0,1.0,1.0
Q38_A10,1,Multiple myeloma is an incurable haematological cancer.,Multiple myeloma is an incurable hematological (blood) cancer.,1.0,1.0,1.0,1.0
Q38_A10,2,The increase in targeted therapies has improved the number of myeloma patients achieving a complete response and improved progression-free survival following therapy.,The increase in specified therapies has improved the number of myeloma patients achieving a complete response and improved progression-free survival after therapy.,0.0,0.0,0.0,0.0
Q38_A10,3,"However, a low level of disease or minimal residual disease (MRD) still persists which contributes to the inevitable relapse in myeloma patients.","However, a low disease level or minimal residual disease (MRD), amount of cancer cells left in the body, still occurs and contributes to relapse in myeloma patients.",0.0,1.0,1.0,0.0
Q38_A10,4,"MRD has been attributed to the presence of dormant myeloma cells and their subsequent reactivation, which is controlled by the microenvironment and specialised niches within the bone marrow.",MRD has been linked to the presence of dormant myeloma cells and their reactivation. This is controlled by the microenvironment and specialized bone marrow zones.,1.0,-1.0,1.0,1.0
Q38_A10,5,"This contributes to the evasion of the immune system and chemotherapy, eventually leading to relapse.","This helps harmful cells avoid the immune system and chemotherapy, leading to relapse.",1.0,1.0,1.0,1.0
Q38_A10,6,"The growth of myeloma tumours are heavily dependent on environmental stimuli from the bone marrow microenvironment, and this plays a key role in myeloma progression.",Myeloma tumor growth is very dependent on environmental prompts from the bone marrow microenvironment. This is important in myeloma progression.,1.0,0.0,1.0,1.0
Q38_A10,7,The bone microenvironment also plays a critical role in myeloma bone disease and the development of skeletal-related events.,Bone microenvironment plays a key role in myeloma bone disease and the development of skeletal issues.,1.0,0.0,1.0,1.0
Q38_A10,8,This review focuses on the bone marrow microenvironment in relation to myeloma pathogenesis and cancer dormancy.,This review focuses on the bone marrow microenvironment in relation to myeloma disease development and cancer dormancy.,0.0,0.0,1.0,1.0
Q38_A10,9,"Moreover, it reviews the current therapies targeting the bone microenvironment to treat myeloma and myeloma bone disease.",It reviews the current therapies targeting the bone microenvironment to treat myeloma and myeloma bone disease.,1.0,-1.0,1.0,1.0
Q38_A10,10,"Lastly, it identifies novel therapeutic targets for myeloma treatment and the associated bone disease.",It identifies new therapeutic targets for myeloma treatment and the associated bone disease.,1.0,0.0,1.0,1.0
Q39_A8,1,"Breastfed infants have a growth pattern that is different from formula-fed infants, which is regarded as the optimal growth pattern.",Breastfed infants have a growth pattern that is different from formula-fed infants. Growth patterns of formula-fed infants are preferred.,1.0,1.0,1.0,1.0
Q39_A8,2,"Breastfed infants increase more in weight, length, and BMI during the first 2-3 months of life and then have a slower growth velocity up to 12 months.","Breastfed infants increase more in weight, length, and BMI during the first 2-3 months of life and then slow in growth up to 12 months.",0.0,1.0,1.0,1.0
Q39_A8,3,They also have a higher accumulation of fat during early infancy.,They also have a higher fat buildup during early infancy.,1.0,1.0,1.0,1.0
Q39_A8,4,"Breastfed infants have lower levels of circulating IGF-I and insulin, which could be part of the explanation of their growth pattern.",Breastfed infants have lower levels of circulating hormones that effect growth and insulin. This may explain their growth pattern.,1.0,1.0,1.0,1.0
Q39_A8,5,Many studies and meta-analyses have examined the association between breastfeeding and later obesity.,Many studies have examined the link between breastfeeding and later obesity.,1.0,1.0,1.0,1.0
Q39_A8,6,"Most find a moderate reduction in the risk of later obesity, but it has been argued that this could be biased due to residual confounding and reverse causation.",Most find slightly decreased risk of later obesity. It has been argued that this could be untrue due to other factors or lack of relation of the two events.,1.0,1.0,1.0,1.0
Q39_A8,7,"From studies in low- and middle-income countries randomizing women to breastfeeding promotion, there was only little effect on early growth.",Studies in low- and middle-income countries found only little effect on early growth from breastfeeding promotion in women.,1.0,1.0,1.0,1.0
Q39_A8,8,"Recent studies have found associations between breast milk composition (total fat, protein, human milk oligosaccharides, adiponectin, leptin, and insulin) and growth.","Recent studies have found links between breast milk composition (e.g. fat, protein) and growth.",1.0,1.0,1.0,1.0
Q39_A8,9,"However, the studies are few, and the results are inconsistent.","However, the studies are few and results are inconsistent.",1.0,1.0,1.0,1.0
Q39_A8,10,"More studies, including studies of maternal factors influencing breast milk composition, are needed to better understand how breastfeeding influences current and later growth and thereby short- and long-term health.",More studies are needed to better understand how breastfeeding influences current and later growth. These studies should focus on maternal factors that may affect breast milk composition.,1.0,1.0,1.0,1.0
Q40_A1,1,"Constipation is a disorder of gastrointestinal motility characterized by difficult or decreased bowel movements, and is a common condition in Western countries.","Constipation is a disorder of gastrointestinal motility, or gut movement. It is characterized by difficult or decreased bowel movements. It is a common condition in Western countries.",1.0,1.0,1.0,1.0
Q40_A1,2,Laxatives are the most common strategy for managing constipation.,Laxatives are the most common way to manage constipation.,1.0,1.0,1.0,1.0
Q40_A1,3,"However, long-term use of some laxatives may be associated with harmful side-effects including increased constipation and fecal impaction.","However, long-term use of some laxatives may be linked with harmful side-effects, such as increased constipation and fecal impaction.",1.0,0.0,1.0,1.0
Q40_A1,4,"Abdominal massage, once an accepted method of treating constipation, is no longer standard of care, but may be a desirable therapy for this condition because it is inexpensive, non-invasive, free of harmful side-effects, and can be performed by patients themselves.","Abdominal massage was once an accepted method of treating constipation. It is no longer standard of care, but may be a desirable therapy for this condition. Abdominal massage is inexpensive, non-invasive, free of harmful side-effects, and can be performed by patients themselves.",1.0,0.0,1.0,1.0
Q40_A1,5,"However, until recently, evidence for its effectiveness was not strong enough to make a recommendation for its use in constipated patients.","However, until recently, evidence for its effectiveness was not strong enough to recommend its use in constipated patients.",1.0,1.0,1.0,1.0
Q40_A1,6,"In 1999, Ernst reviewed all available controlled clinical trials, and found that there was no sound evidence for the effectiveness of abdominal massage in the treatment of chronic constipation.","In 1999, Ernst reviewed available scientific papers and found that there was no sound evidence for the effectiveness of abdominal massage in the treatment of chronic constipation.",0.0,1.0,1.0,1.0
Q40_A1,7,"This article reviews scientific evidence from 1999 to the present, regarding abdominal massage as an intervention for chronic constipation.",This article reviews scientific evidence from 1999 to the present to evaluate abdominal massage as an intervention for chronic constipation.,1.0,0.0,1.0,1.0
Q40_A1,8,"Since that time, studies have demonstrated that abdominal massage can stimulate peristalsis, decrease colonic transit time, increase the frequency of bowel movements in constipated patients, and decrease the feelings of discomfort and pain that accompany it.","New studies have demonstrated that abdominal massage can stimulate peristalsis (contraction and relaxation of muscles), decrease time it takes for a bowel movement to go through the intestines, increase bowel movement frequency, and decrease discomfort and pain.",-1.0,1.0,1.0,1.0
Q40_A1,9,There is also good evidence that massage can stimulate peristalsis in patients with post-surgical ileus.,There is also good evidence that massage can stimulate peristalsis in patients with lack of muscle control in their intestines due to surgery.,1.0,1.0,1.0,1.0
Q40_A1,10,"Individual case reports show that massage has been effective for patients with constipation due to a variety of diagnosed physiologic abnormalities, as well as in patients with long-term functional constipation.","Reports show that massage has been effective for patients with constipation due to a variety of bodily reasons, as well as in patients with long-term functional constipation.",0.0,0.0,1.0,1.0
